{"text": "The aim of the current study is to test the clinical performance of the everolimus - eluting BVS compared with that of the durable polymer everolimus - eluting stent ( EES ) in patients undergoing PCI in the setting of acute MI .", "label": "", "metadata": {}, "score": "27.701252"}
{"text": "View at Google Scholar .Studies show everolimus - eluting stent implantation reduces restenosis and repeat revasculariztion . ...Two new studies have determined that everolimus - eluting stent ( EES ) im ...", "label": "", "metadata": {}, "score": "29.304852"}
{"text": "This study assessed vascular healing at 9-month follow up after implantation of everolimus- and biolimus - eluting stents ( EES ; BES ) and everolimus - eluting BVS .", "label": "", "metadata": {}, "score": "31.224863"}
{"text": "Evaluation of the second generation of a bioresorbable everolimus drug - eluting vascular scaffold for treatment of de novo coronary artery stenosis : six - month clinical and imaging outcomes .", "label": "", "metadata": {}, "score": "31.629887"}
{"text": "A Prospective Randomized Study to Compare Vascular Healing After Deployment of the Abluminal Sirolimus Coated Bio - Engineered ( Combo ) Stent Versus the Everolimus Eluting Stent in Patients With Acute Coronary Syndrome by Means of OCT .", "label": "", "metadata": {}, "score": "34.69445"}
{"text": "New - generation metallic DES ( EES / BES ) were not superior to BVS in terms of angiographic LLL and clinical outcomes .( Comparison of Everolimus- and Biolimus - Eluting Stents With Everolimus - Eluting Bioresorbable Vascular Scaffold Stents [ EVERBIO II ] ; NCT01711931 ) .", "label": "", "metadata": {}, "score": "35.00022"}
{"text": "Serial in vivo intravascular ultrasound - based echogenicity changes of everolimus - eluting bioresorbable vascular scaffold during the first 12 months after implantation insights from the ABSORB B trial .", "label": "", "metadata": {}, "score": "35.214813"}
{"text": "Everolimus - eluting stents ( EES ) and biolimus - eluting stents ( BES ) are more recent DES that have been widely investigated .The EES is at present the most frequently used DES in the USA and in Europe [ 3 ] .", "label": "", "metadata": {}, "score": "35.944046"}
{"text": "The effectiveness of sirolimus - eluting stents in unselected patients treated in the daily practice is currently unknown ... .Endothelial - dependent vasomotion in a coronary segment treated by ABSORB everolimus - eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer : indirect finding of vascular reparative therap .", "label": "", "metadata": {}, "score": "36.960377"}
{"text": "Increased utilization of distal protection devices might reduce the peri - procedural rate of AMI ... .Very long sirolimus - eluting stent implantation for de novo coronary lesions .", "label": "", "metadata": {}, "score": "38.34675"}
{"text": "Second - generation everolimus - eluting stents ( EES ) and third generation biolimus - eluting stents ( BES ) have been shown to be superior to first - generation paclitaxel - eluting stents ( PES ) and second - generation sirolimus - eluting stents ( SES ) .", "label": "", "metadata": {}, "score": "38.973312"}
{"text": "Study Arm ( s ) .Experimental : Combo Stent .PTCA with Combo Stent .Intervention : Device : PTCA with stent placement .Active Comparator : Everolimus Eluting Stent ( EES ) .", "label": "", "metadata": {}, "score": "39.200363"}
{"text": "The type of lesion being treated and lesion morphology also influence healing after treatment with DES and can contribute to ST .Second - generation DES such as the XIENCE V everolimus - eluting stent differ from the first - generation stents with respect to antiproliferative agents , coating technologies , and stent frame .", "label": "", "metadata": {}, "score": "40.683342"}
{"text": "To assess serially the edge vascular response ( EVR ) of a bioresorbable vascular scaffold ( BVS ) compared to a metallic everolimus - eluting stent ( EES ) ... .", "label": "", "metadata": {}, "score": "40.84601"}
{"text": "View at Google Scholar .J. B. Hermiller , K. Sudhir , R. J. Applegate et al . , \" Impact of age on clinical outcomes after everolimus - eluting and paclitaxel - eluting stent implantation : pooled analysis from the SPIRIT III and SPIRIT IV Clinical Trials , \" EuroIntervention , vol . 8 , pp .", "label": "", "metadata": {}, "score": "40.85508"}
{"text": "Of interest , in patients with diabetes , a further analysis analysis of 22,844 patient years of follow - up from randomised trials , relative differences were observed among the drug - eluting stents , such that the XIENCE V everolimus eluting stent was the most efficacious and safe [ 62 ] .", "label": "", "metadata": {}, "score": "41.416046"}
{"text": "Descriptive Information .Brief Title ICMJE .Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT .", "label": "", "metadata": {}, "score": "41.575085"}
{"text": "Elective sirolimus - eluting stent implantation for left main coronary artery disease : six - month angiographic follow - up and 1-year clinical outcome .", "label": "", "metadata": {}, "score": "43.170467"}
{"text": "The present study evaluates the clinical outcomes following sirolimus - eluting stent implantation for ostial lesions ... .Effectiveness of the sirolimus - eluting stent in the treatment of saphenous vein graft disease .", "label": "", "metadata": {}, "score": "44.61257"}
{"text": "A comparison of the conformability of everolimus - eluting bioresorbable vascular scaffolds to metal platform coronary stents .Josep Gomez - Lara Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 3:1190 - 8 .", "label": "", "metadata": {}, "score": "45.158592"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Second - generation everolimus - eluting stents ( EES ) and third generation biolimus - eluting stents ( BES ) have been shown to be superior to first - generation paclitaxel - eluting stents ( PES ) and second - generation sirolimus - eluting stents ( SES ) .", "label": "", "metadata": {}, "score": "45.85427"}
{"text": "409 - 412 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .In press .R. Diletti , V. Farooq , C. Girasis et al . , \" Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels .", "label": "", "metadata": {}, "score": "45.982162"}
{"text": "The aim of our study was to compare the local endothelial function assessed by exercise induced coronary vasomotion after implantation of a biolimus A9-eluting stent with biodegradable polymer ( BES ) with an everolimus - eluting stent with durable polymer ( EES ) .", "label": "", "metadata": {}, "score": "46.45304"}
{"text": "The EVERBIO II ( Comparison of Everolimus- and Biolimus - Eluting Stents With Everolimus - Eluting Bioresorbable Vascular Scaffold Stents II ) trial was a single - center , assessor - blinded study of 240 patients randomly assigned in a 1:1:1 ratio to EES , BES , or BVS .", "label": "", "metadata": {}, "score": "46.54853"}
{"text": "BES : biolimus - eluting stent , BVS : biovascular scaffold , EES : everolimus - eluting stent , OCT : optical coherence tomography , PCI : percutaneous coronary intervention .", "label": "", "metadata": {}, "score": "46.95333"}
{"text": "9824 , pp .1393 - 1402 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Palmerini , A. J. Kirtane , P. W. Serruys et al . , \" Stent thrombosis with everolimus - eluting stents : meta - analysis of comparative randomized controlled trials , \" Circulation , vol .", "label": "", "metadata": {}, "score": "47.2165"}
{"text": "Head - to - head comparison of the neointimal response between metallic and bioresorbable everolimus - eluting scaffolds using optical coherence tomography .Josep Gomez - Lara Department of Interventional Cardiology , Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 4:1271 - 80 .", "label": "", "metadata": {}, "score": "48.081425"}
{"text": "Puricel S , Oberh\u00e4nsli M , Guntern P , Lehmann S , Goy JJ , Arroyo D , Villeneuve H , Baeriswyl G , Stauffer JC , Togni M , Cook S : Long - term comparison of everolimus - eluting and biolimus - eluting stents .", "label": "", "metadata": {}, "score": "48.747555"}
{"text": "The unresolved problem of neointimal proliferation and very late stent thrombosis from lingering polymers and vascular scaffolds , led to the development of new - generation completely resorbable stents .", "label": "", "metadata": {}, "score": "48.893272"}
{"text": "Background We aimed to clarify the differences in vessel healing after stenting for bifurcation lesions using sirolimus - eluting stent ( SES ) or everolimus - eluting stent ( EES ) .", "label": "", "metadata": {}, "score": "49.125122"}
{"text": "A second - generation device was developed to overcome the initial limitations of early scaffold shrinkage and provide greater radial support .Putative advantages over conventional DES are early restoration of physiological processes , namely vasomotion and remodeling , superior conformability , beneficial edge - vascular response and suppression of late - stent malapposition [ 27 ] .", "label": "", "metadata": {}, "score": "49.61737"}
{"text": "This is mainly due to lack of good in vitro and animal models which makes mechanistic studies difficult ... .Effectiveness of sirolimus - eluting stent implantation for recurrent in - stent restenosis after brachytherapy .", "label": "", "metadata": {}, "score": "49.638542"}
{"text": "Results show the rate of major cardiac adverse events in EES - treated patients with calcified lesions were higher than in those for noncalcified lesions , but remained lower than the results of previously reported stent studies .", "label": "", "metadata": {}, "score": "50.067535"}
{"text": "The present study demonstrates that the bioresorption process in patients who undergoing BVS device implantation can be assessed using VH - IVUS analysed using Shin 's method .", "label": "", "metadata": {}, "score": "50.075493"}
{"text": "Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus - Eluting fully bioresorbable vascular scaffold : optical coherence tomography assessment in the ABSORB cohort B Trial ( .", "label": "", "metadata": {}, "score": "50.11158"}
{"text": "Although large population studies with long - term follow - up are mandatory , the authors concluded that EES implantation for calcified culprit lesions appears to be safe up to 3 years .", "label": "", "metadata": {}, "score": "50.437458"}
{"text": "Keywords .Biolimus - eluting stent Bioresorbable vascular scaffold ( BVS ) Coronary artery disease Drug - eluting stent Everolimus - eluting stent Late lumen loss Percutaneous coronary intervention .", "label": "", "metadata": {}, "score": "51.086475"}
{"text": "Therefore , concerns about the long - term outcome and safety after drug - eluting stent implantation due to late stent thrombosis and late stent malapposition have been raised .", "label": "", "metadata": {}, "score": "51.334496"}
{"text": "10.1016/j.jacc.2006.03.042 View Article PubMed .Kedhi E , Joesoef KS , McFadden E , Wassing J , van Mieghem C , Goedhart D , Smits PC : Second - generation everolimus - eluting and paclitaxel - eluting stents in real - life practice ( COMPARE ) : a randomised trial .", "label": "", "metadata": {}, "score": "52.416763"}
{"text": "Previous studies have indicated , that coronary stent healing after DES implantation is particularly impaired in patients with ACS , and therefore this patient population is in a particular need of improved \" pro - healing \" stent concepts with a high efficacy .", "label": "", "metadata": {}, "score": "52.803528"}
{"text": "9773 , pp .1241 - 1247 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Kedhi , K. S. Joesoef , E. McFadden et al . , \" Second - generation everolimus - eluting and paclitaxel - eluting stents in real - life practice ( COMPARE ) : a randomised trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "52.864174"}
{"text": "Over time , fibrous atherosclerotic plaques develop , narrowing the arteries and thereby limiting coronary blood flow .At this stage , coronary artery disease can be asymptomatic or associated with angina pectoris , and it is typically accompanied by calcification of the atherosclerotic plaque .", "label": "", "metadata": {}, "score": "53.178726"}
{"text": "Third - generation biolimus - eluting stents ( BES ) have been found to be non - inferior to PES .To date , there is no available comparative study between EES and BES .", "label": "", "metadata": {}, "score": "53.437737"}
{"text": "Its non - inferiority to the Xience Prime ( Abbott Vascular ) , an EES , is currently under investigation in the international ABSORB EXTEND trial that plans to enroll 1,000 patients ( NCT01023789 ) .", "label": "", "metadata": {}, "score": "53.62275"}
{"text": "STUDY DESIGN The REMEDEE OCT study is a prospective , multicenter , randomized study designed to enroll 60 patients with ACS who will be randomized 1:1 to be treated with the Combo stent versus the commercially available everolimus eluting stent ( Xience V or Promus ) .", "label": "", "metadata": {}, "score": "54.019535"}
{"text": "Sirolimus - eluting stent implantation in ST - elevation acute myocardial infarction : a clinical and angiographic study .Francesco Saia Department of Interventional Cardiology , Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands Circulation 108:1927 - 9 .", "label": "", "metadata": {}, "score": "54.25709"}
{"text": "Effectiveness of sirolimus - eluting stent implantation for the treatment of coronary artery disease in octogenarians .Maniyal Vijayakumar Erasmus Medical Center , Thoraxcenter , Rotterdam , The Netherlands Am J Cardiol 94:909 - 13 .", "label": "", "metadata": {}, "score": "54.39344"}
{"text": "Although initial results with BVS are encouraging , there is a lack of randomized clinical trial data and no data exists for outcomes after BVS implantation in patients undergoing coronary stenting in the setting of acute myocardial infarction ( MI ) .", "label": "", "metadata": {}, "score": "54.453453"}
{"text": "The aim of this study was to assess sirolimus - eluting stent ( SES ) implantation for the treatment of chronic total coronary occlusions ( CTO ) ... .", "label": "", "metadata": {}, "score": "54.66749"}
{"text": "4 , pp .236 - 246 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. T. L. Ong , A. Hoye , J. Aoki et al . , \" Thirty - day incidence and six - month clinical outcome of thrombotic stent occlusion after bare - metal , sirolimus , or paclitaxel stent implantation , \" Journal of the American College of Cardiology , vol .", "label": "", "metadata": {}, "score": "54.716103"}
{"text": "Effectiveness of the sirolimus - eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery .Angela Hoye Department of Cardiology , Thoraxcenter , Erasmus Medical Centre , Rotterdam , The Netherlands Coron Artery Dis 15:171 - 5 .", "label": "", "metadata": {}, "score": "54.859062"}
{"text": "Effectiveness of the sirolimus - eluting stent in the treatment of patients with a prior history of coronary artery bypass graft surgery .Angela Hoye Department of Cardiology , Thoraxcenter , Erasmus Medical Centre , Rotterdam , The Netherlands Coron Artery Dis 15:171 - 5 .", "label": "", "metadata": {}, "score": "54.859062"}
{"text": "Salvatore Brugaletta Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 4:1281 - 9 .Elective sirolimus - eluting stent implantation for multivessel disease involving significant LAD stenosis : one - year clinical outcomes of 99 consecutive patients -- the Rotterdam experience .", "label": "", "metadata": {}, "score": "54.895554"}
{"text": "143 - 151 , 2000 .View at Google Scholar \u00b7 View at Scopus .P. W. Serruys , P. Ruygrok , J. Neuzner et al . , \" randomised comparison of an everolimus - eluting coronary stent with a paclitaxel - eluting coronary stent : the SPIRIT II trial , \" EuroIntervention , vol .", "label": "", "metadata": {}, "score": "54.906242"}
{"text": "The edge vascular response following implantation of the Absorb everolimus - eluting bioresorbable vascular scaffold and the XIENCE V metallic everolimus - eluting stent .First serial follow - up assessment at six months and two years : insights from the first - i .", "label": "", "metadata": {}, "score": "54.91721"}
{"text": "Therefore , we investigated the impact of SES on the clinical practice of CABG and PCI in a series of unselected consecutive patients ... .Significant reduction in restenosis after the use of sirolimus - eluting stents in the treatment of chronic total occlusions .", "label": "", "metadata": {}, "score": "54.946785"}
{"text": "Type D patients experience increased negative emotions and tend not to express these emotions in social interactions ... .The everolimus - eluting stent in real - world patients : 6-month follow - up of the X - SEARCH ( Xience V Stent Evaluated at Rotterdam Cardiac Hospital ) registry .", "label": "", "metadata": {}, "score": "55.87777"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The aim of this analysis was to compare the long - term safety and efficacy of the biodegradable polymer biolimus - eluting stent ( BES ) with that of the durable polymer everolimus - eluting stent ( EES ) .", "label": "", "metadata": {}, "score": "56.15105"}
{"text": "However effective neointimal suppression occurs at the cost of a systematic delay in arterial healing in comparison with after bare metal stenting .This underlies a small but significant increased risk of stent thrombosis after DES implantation in comparison with bare metal stent implantation as well as a possible excess of in - stent neoatheroma formation .", "label": "", "metadata": {}, "score": "56.18892"}
{"text": "188 - 195 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. C. Smits , S. Hofma , M. Togni et al . , \" Abluminal biodegradable polymer biolimus - eluting stent versus durable polymer everolimus - eluting stent ( COMPARE II ) : a randomised , controlled , noninferiority trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "56.20619"}
{"text": "S. Windecker , P. W. Serruys , S. Wandel et al . , \" Biolimus - eluting stent with biodegradable polymer versus sirolimus - eluting stent with durable polymer for coronary revascularisation ( LEADERS ) : a randomised non - inferiority trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "56.312653"}
{"text": "Sirolimus - eluting stents for the treatment of atherosclerotic ostial lesions .Maniyal Vijayakumar Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands J Invasive Cardiol 17:10 - 2 .", "label": "", "metadata": {}, "score": "57.086433"}
{"text": "Potential benefits include restoration of normal vasomotor reactivity , facilitation of positive vessel wall remodelling and facilitation of subsequent bypass grafting of the stented arterial segment .", "label": "", "metadata": {}, "score": "57.137726"}
{"text": "The second - generation XIENCE EES has been shown to be superior to a first - generation TAXUS PES in preventing the clinical manifestations of stent thrombosis in label patients [ 47 ] , real - world patients [ 48 ] , and those with acute coronary syndrome [ 49 ] .", "label": "", "metadata": {}, "score": "57.265648"}
{"text": "Intervention : Device : PTCA with stent placement .Not Provided .Recruitment Information .Recruitment Status ICMJE .Completed .Enrollment ICMJE .Completion Date .", "label": "", "metadata": {}, "score": "57.419296"}
{"text": "Methods J apanese R egistry Study in Comparison Between Ever olimus - Eluting Stent and S irolimus- E luting Stent for the Bifurcation Lesion ( J - REVERSE ) is a prospective multicentre registry of 303 bifurcation lesions that were treated with provisional SES or EES with or without final kissing inflation .", "label": "", "metadata": {}, "score": "57.538795"}
{"text": "This study investigated the clinical outcomes of patients with ST - segment elevation myocardial infarction ( MI ) treated with sirolimus - eluting stents ( SESs ) or with conventional bare stents ... .", "label": "", "metadata": {}, "score": "57.601097"}
{"text": "Clinical and angiographic outcomes after overdilatation of undersized sirolimus - eluting stents with largely oversized balloons : an observational study .Francesco Saia Erasmus MC , Thoraxcenter , Rotterdam , The Netherlands Catheter Cardiovasc Interv 61:455 - 60 .", "label": "", "metadata": {}, "score": "57.88999"}
{"text": "Francesco Saia Thoraxcenter , Erasmus University Medical Center , Rotterdam , The Netherlands Catheter Cardiovasc Interv 62:283 - 8 .The result of this nonrandomized study suggests that sirolimus - eluting stent implantation is at least as effective as vascular brachytherapy in the treatment of in - stent restenosis ... . Short- and long - term clinical benefit of sirolimus - eluting stents compared to conventional bare stents for patients with acute myocardial infarction .", "label": "", "metadata": {}, "score": "58.183746"}
{"text": "Ideally , the device would offer an acute transient radial strength and later be completely absorbed thereby restoring vascular physiology .Several DES using bioresorbable materials are currently available .", "label": "", "metadata": {}, "score": "58.25197"}
{"text": "141 - 149 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. V. Finn , F. D. Kolodgie , J. Harnek et al . , \" Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel - eluting stents , \" Circulation , vol .", "label": "", "metadata": {}, "score": "58.330704"}
{"text": "Josep Gomez - Lara Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 4:992 - 1001 .Type D personality predicts death or myocardial infarction after bare metal stent or sirolimus - eluting stent implantation : a Rapamycin - Eluting Stent Evaluated at Rotterdam Cardiology Hospital ( RESEARCH ) registry substudy .", "label": "", "metadata": {}, "score": "58.608566"}
{"text": "With its widespread clinical launch in 2012 , little is known on the broader use in more complex cases or acute coronary syndromes .The use of the BVS in complex situations makes sense however , as the risk of long - term complications from conventional DES implantation is even higher ( longer lesions , chronic total occlusion , acute coronary syndromes and so on ) .", "label": "", "metadata": {}, "score": "58.665024"}
{"text": "Kengo Tanabe Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands Am J Cardiol 94:115 - 8 .Effectiveness of sirolimus - eluting stent implantation for the treatment of coronary artery disease in octogenarians .", "label": "", "metadata": {}, "score": "58.812355"}
{"text": "However , at the present time , the clinical value of genetic testing for CYP2C19 polymorphisms or platelet reactivity is uncertain .Of note , the Gravitas trial showed no benefit for doubling the standard daily dose of clopidogrel from 75 to 150 mg per day after PCI in patients with heightened on - treatment platelet reactivity [ 81 ] .", "label": "", "metadata": {}, "score": "58.88188"}
{"text": "Summary .Publications .Catheter - based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure : clinical experience with six - month follow - up .", "label": "", "metadata": {}, "score": "58.95217"}
{"text": "Improvements in stent structure may result in better stent apposition to the vessel wall , improved endothelialization , and reduced platelet aggregation and thrombus formation , thereby reducing the incidence of ST [ 51 ] .", "label": "", "metadata": {}, "score": "58.989574"}
{"text": "Clinical , angiographic , and procedural predictors of angiographic restenosis after sirolimus - eluting stent implantation in complex patients : an evaluation from the Rapamycin - Eluting Stent Evaluated At Rotterdam Cardiology Hospital ( RESEARCH ) study .", "label": "", "metadata": {}, "score": "59.056053"}
{"text": "However OCT is still an ( minimally ) invasive procedure .Multislice ... .Background - Although in - stent restenosis ( ISR ) after bare - metal stent ( BMS ) implantation peaks in the early phase , very late ( VL )", "label": "", "metadata": {}, "score": "59.083878"}
{"text": "This is primarily due to a hypersensitivity reaction with secondary delayed arterial healing [ 24 , 25 ] .Substantial efforts have been made during the last decade to develop bioresorbable materials such as transient polymers or temporary ' scaffolds ' .", "label": "", "metadata": {}, "score": "59.820663"}
{"text": "The use of intravascular ultrasound , used in 41 % of the procedures , was not associated with additional clinical benefit with respect to angiographic - assisted stent deployment ... .", "label": "", "metadata": {}, "score": "59.836117"}
{"text": "Significantly less endothelial strut coverage at 14 days was more apparent in earlier stent designs with CYPHER or TAXUS relative to the newer XIENCE V or ENDEAVOR .", "label": "", "metadata": {}, "score": "59.84101"}
{"text": "Late - acquired incomplete stent apposition , a phenomenon observed relatively more frequently with DES implantation compared with BMS implantation , may result from focal vascular remodeling and dissolution of thrombus .", "label": "", "metadata": {}, "score": "59.925095"}
{"text": "We studied efficiency and retention of transendomyocardial injections with a NOGA guided injection catheter system by using scintigraphy with radio - labeled model drugs ... .", "label": "", "metadata": {}, "score": "59.930832"}
{"text": "These findings were further confirmed in a recent network analysis of 12,453 patients with ST - segment elevation myocardial infarction , where the XIENCE cobalt - chromium EES was associated with lower cardiac death , MI , and ST rates than BMS [ 64 ] .", "label": "", "metadata": {}, "score": "60.06974"}
{"text": "Dr. Applegate concluded , \" Our observations confirm previous studies demonstrating a relative increase in the incidence of periprocedural elevation of biomarkers with PES use , and demonstrate the absence of this phenomenon with EES . \"", "label": "", "metadata": {}, "score": "60.83683"}
{"text": "9 - 15 , 2004 .View at Google Scholar \u00b7 View at Scopus .J. L. Orford , R. Lennon , S. Melby et al . , \" Frequency and correlates of coronary stent thrombosis in the modern era : analysis of a single center registry , \" Journal of the American College of Cardiology , vol .", "label": "", "metadata": {}, "score": "60.89114"}
{"text": "2-year follow - up of a randomized controlled trial of everolimus- and paclitaxel - eluting stents for coronary revascularization in daily practice .COMPARE ( Comparison of the everolimus eluting XIENCE - V stent with the paclitaxel eluting TAXUS LIBERT\u00c9 stent i .", "label": "", "metadata": {}, "score": "60.92798"}
{"text": "17 , pp .1084 - 1089 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Daemen , P. Wenaweser , K. Tsuchida et al . , \" Early and late coronary stent thrombosis of sirolimus - eluting and paclitaxel - eluting stents in routine clinical practice : data from a large two - institutional cohort study , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "61.07071"}
{"text": "The development , clinical validation and widespread use of drug - eluting stents ( DES ) have revolutionized the treatment of patients with coronary artery disease .", "label": "", "metadata": {}, "score": "61.110386"}
{"text": "[ 68 ] .Of note , a case report of late ST , 5 months after NOBORI implantation , associated with accelerated neoatherosclerosis and early manifestation of neointimal rupture , suggests that larger studies and continued vigilance are necessary [ 69 ] .", "label": "", "metadata": {}, "score": "61.353943"}
{"text": "Following favorable results with this device in the SPIRIT FIRST randomized study , the SPIRIT II and III trials were performed to evaluate the EES in comparison with the widely used TAXUS paclitaxel - eluting stent ( PES ) in the treatment of patients with coronary artery disease .", "label": "", "metadata": {}, "score": "61.50761"}
{"text": "Official Title : .Intracoronary Scaffold Assessment a Randomised Evaluation of Absorb in Myocardial Infarction ( ISAR - Absorb MI )A Prospective , Randomized Trial of BVS Veruss EES in Patients Undergoing Coronary Stenting for Myocardial Infarction .", "label": "", "metadata": {}, "score": "61.72811"}
{"text": "15 , pp .1967 - 1971 , 2001 .View at Google Scholar \u00b7 View at Scopus .I. Iakovou , T. Schmidt , E. Bonizzoni et al . , \" Incidence , predictors and outcome of thrombosis after succesful implantation of drug - eluting stents , \" Journal of the American Medical Association , vol .", "label": "", "metadata": {}, "score": "61.796265"}
{"text": "Sirolimus - eluting stent for treatment of complex in - stent restenosis : the first clinical experience .Muzaffer Degertekin Thoraxcenter , University Hospital Rotterdam , The Netherlands J Am Coll Cardiol 41:184 - 9 .", "label": "", "metadata": {}, "score": "61.99388"}
{"text": "Recovery of a normal endothelial - dependent vasomotion may be enabled by scaffold bioresorption , composition of the underlying tissue , or a combination of both mechanisms ... .", "label": "", "metadata": {}, "score": "62.137325"}
{"text": "Paris , France and Principal Investigator ... France and Germany .Although patients ... .Assessment of the serial changes of vessel wall contents in atherosclerotic coronary lesion with bioresorbable everolimus - eluting vascular scaffolds using Shin 's method : an IVUS study .", "label": "", "metadata": {}, "score": "62.180687"}
{"text": "The Wake Forest researchers identified 113 patients in the EES group and 63 patients in the PES group who met the criteria of having a lesion with a jailed side branch ( less than 2 mm diameter , and less than 50 % stenosis ) .", "label": "", "metadata": {}, "score": "62.33043"}
{"text": "1500 - 1510 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. J. Wilson , G. Nakazawa , R. S. Schwartz et al . , \" Comparison of inflammatory response after implantation of sirolimus- and paclitaxel - eluting stents in porcine coronary arteries , \" Circulation , vol .", "label": "", "metadata": {}, "score": "62.425377"}
{"text": "CFR will be assessed using transthoracic echocardiography with adenosine infusion .Other Name : Xience - V stent , Abbott vascular , USA .Objective : The aim of the trial is to assess coronary artery reactivity using adenosine - induced coronary flow reserve ( CFR ) by transthoracic echocardiography in patients with Bio - active stent ( BAS ) and Everolimus - eluting stent ( EES ) distal to the original culprit lesion at 6 - 8 months .", "label": "", "metadata": {}, "score": "62.50512"}
{"text": "53 .Multislice computed tomography ( MSCT ) is a promising technique for noninvasive coronary evaluation .We evaluated the diagnostic performance of high - resolution MSCT to detect ISR after stenting of the LMCA ... .", "label": "", "metadata": {}, "score": "62.509792"}
{"text": "Data derived from studies of first generation stents have demonstrated that ST after DES can be delayed , with an annual incidence of 0.2 - 0.3 % in patients with noncomplex coronary artery disease [ 45 ] and 0.4 - 0.6 % in real - world patients [ 46 ] .", "label": "", "metadata": {}, "score": "62.646496"}
{"text": "In addition , the plaque may rupture , due to the atherosclerotic burden , leading to vessel occlusion , blood flow interruption , and acute coronary syndrome .", "label": "", "metadata": {}, "score": "62.651463"}
{"text": "The aim of this study is to evaluate the relationship between plaque morphology obtained by optical coherence tomography ( OCT ) and arterial remodelling .Methods and results OCT and intravascular ultrasound imaging pull back was performed at corresponding sites on 94 lesions in 47 patients .", "label": "", "metadata": {}, "score": "62.66266"}
{"text": "PCI dates back to the introduction of balloon angioplasty by Gruentzig [ 10 ] .Early in the BMS experience , subacute ST was a common occurrence until adequate stent sizing , high - pressure deployment , and postdilation were introduced [ 11 ] , along with routine antithrombotic therapy [ 12 ] .", "label": "", "metadata": {}, "score": "62.700672"}
{"text": "The EVERBIO II trial will assess BVS efficacy compared to the latest DES on the market in all patients viable for inclusion experiencing more complex lesions and clinical situations .", "label": "", "metadata": {}, "score": "62.887177"}
{"text": "Detail Information .Publications 56 .Catheter - based intramyocardial injection of autologous skeletal myoblasts as a primary treatment of ischemic heart failure : clinical experience with six - month follow - up .", "label": "", "metadata": {}, "score": "63.066498"}
{"text": "Mean computed tomographic density value of ... .Objectives : The purpose of this study was to assess the prevalence and to quantify the thin - cap fibroatheroma ( TCFA ) and ruptured plaques in patients with coronary artery disease using optical coherence tomography ( OCT ) .", "label": "", "metadata": {}, "score": "63.122017"}
{"text": "There is experimental evidence that transplanting skeletal myoblasts ( SM ) into the post - infarction myocardial scar improves regional and global left ventricular ( LV ) function ... .", "label": "", "metadata": {}, "score": "63.18641"}
{"text": "Stent thrombosis : insights on outcomes , predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II , SPIRIT III , SPIRIT IV and COMPARE trials .", "label": "", "metadata": {}, "score": "63.23837"}
{"text": "View at Publisher \u00b7 View at Google Scholar .T. Palmerini , G. Biondi - Zoccai , D. Della Riva et al . , \" Clinical outcomes with drug - wluting and bare metal stents in patients with ST - segment elevation myocardial infarction : evidence from a comprehensive network meta - analysis , \" Journal of the American College of Cardiology , 2013 .", "label": "", "metadata": {}, "score": "63.339294"}
{"text": "Very late stent thrombosis occurred at an approximate rate of 0.6 % annually for first - generation DES , often presenting as a catastrophic event , with high rates of death ( 20 - 40 % ) or myocardial infarction ( MI ) ( 50 - 70 % ) [ 7 , 14 ] .", "label": "", "metadata": {}, "score": "63.341248"}
{"text": "Thus , SES implantation appears safe and effective for de novo coronary lesions requiring multiple stent placement over a very long vessel segment ... .The impact of the introduction of drug - eluting stents on the clinical practice of surgical and percutaneous treatment of coronary artery disease .", "label": "", "metadata": {}, "score": "63.3596"}
{"text": "+ /- 0.65 mm and one focal restenosis ( 8 % of patients ) .Elective SES implantation for LM disease was associated with zero mortality and a very low incidence of additional major adverse events at 1 year ... .", "label": "", "metadata": {}, "score": "63.534645"}
{"text": "6 , pp .947 - 953 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. K. Kuchulakanti , W. W. Chu , R. Torguson et al . , \" Correlates and long - term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel - eluting stents , \" Circulation , vol .", "label": "", "metadata": {}, "score": "63.573944"}
{"text": "We describe the clinical and morphological patterns of restenosis after sirolimus - eluting stent ( SES ) implantation ... .Unrestricted utilization of sirolimus - eluting stents compared with conventional bare stent implantation in the \" real world \" : the Rapamycin - Eluting Stent Evaluated At Rotterdam Cardiology Hospital ( RESEARCH ) registry .", "label": "", "metadata": {}, "score": "63.598915"}
{"text": "651 - 660 , 2013 .View at Google Scholar . Y. Yang , M. Kim , C. Kim et al . , \" Late stent thrombosis after drug - eluting stent implantation : a rare case of accelerated neo - atherosclerosis and early manifestation of neointimal rupture , \" Korean Circulation Journal , vol .", "label": "", "metadata": {}, "score": "63.686657"}
{"text": "While a reliable and permanent solution for ST has remained elusive so far , considerable progress has been made in decreasing its incidence through optimal deployment techniques , improved stent design , and effective antiplatelet therapies .", "label": "", "metadata": {}, "score": "63.750904"}
{"text": "Bioabsorbable stent , Bioresorption , Virtual Histology intravascular ultrasound .Shin , E.S , Garcia - Garcia , H.M , Garg , S.A , Ligthart , J.M.R , Thuesen , L , Dudek , D , ... Serruys , P.W.J.C. ( 2010 ) .", "label": "", "metadata": {}, "score": "64.51551"}
{"text": "This review will focus on a specific clinical and anatomic subset of coronary thrombosis that can lead to MI and SCD of thrombotic occlusion of a previously - stented coronary artery ( stent thrombosis , ST ) [ 4 - 6 ] .", "label": "", "metadata": {}, "score": "64.6255"}
{"text": "Follow - up coronary angiography .Effectiveness will be measured at the 9-month follow - up angiography in all patients .Quantitative measures will be performed within the stent and the 5 mm edge region .", "label": "", "metadata": {}, "score": "64.706894"}
{"text": "The factors associated with the occurrence of restenosis after sirolimus - eluting stent ( SES ) implantation in complex cases are currently unknown ... .Coronary restenosis after sirolimus - eluting stent implantation : morphological description and mechanistic analysis from a consecutive series of cases .", "label": "", "metadata": {}, "score": "64.75452"}
{"text": "View at Google Scholar . H. K. Win , A. E. Caldera , K. Maresh et al . , \" Clinical outcomes and stent thrombosis following off - label use of drug - eluting stents , \" Journal of the American Medical Association , vol .", "label": "", "metadata": {}, "score": "64.965355"}
{"text": "Cap thickness of fibroatheroma evaluated by Optical coherence tomography ( OCT ) is a major determinant of vulnerable plaque .The primary objective of this study is to evaluate the effect of ezetimibe in addition ... .", "label": "", "metadata": {}, "score": "65.298065"}
{"text": "Restenosis rates following bifurcation stenting with sirolimus - eluting stents for de novo narrowings .Kengo Tanabe Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands Am J Cardiol 94:115 - 8 .", "label": "", "metadata": {}, "score": "65.39169"}
{"text": "Excised mouse aortas containing atherosclerotic plaque were ablated with ultrafast near - infrared ( NIR ) laser pulses .Optical coherence tomography ( OCT ) was used to observe the ablation result , while the physical damage was inspected in histological sections .", "label": "", "metadata": {}, "score": "65.41354"}
{"text": "Postmortem studies conducted 40 months after the placement of DES confirmed poor endothelialization in 45 % of cases [ 16 ] .First - generation DES use may thus be associated with a small increase in ST and in high - risk patient and lesion subsets , an increased risk of death or MI compared with the use of BMS [ 44 ] .", "label": "", "metadata": {}, "score": "65.63682"}
{"text": "However , despite an improved efficacy in the prevention of restenosis and target vessel failure safety concerns have been raised for DES , focusing on a small but clinically important increase in stent thrombosis occurring greater than one year after the index procedure .", "label": "", "metadata": {}, "score": "65.688324"}
{"text": "Patients receiving titanium - nitride - oxide coated stents during the intervention .Device : CFR .CFR will be assessed using transthoracic echocardiography with adenosine infusion .", "label": "", "metadata": {}, "score": "65.7599"}
{"text": "The treatment of calcified coronary stenosis is associated with a high frequency of restenosis and target lesion revascularization ( TLR ) .Drug - eluting stents ( DES ) , known to reduce the rates of restenosis and TLR in patients with relatively simple coronary artery lesions when compared with bare metal stents ( BMS ) , are now successfully being used for more advanced lesions such as calcified coronary stenoses .", "label": "", "metadata": {}, "score": "65.91241"}
{"text": "Methods and results : A group of 814 consecutive patients undergoing percutaneous coronary intervention ( PCI ) was enrolled between 2007 and 2010 , of which 527 were treated with EES and 287 with BES implantation .", "label": "", "metadata": {}, "score": "66.00948"}
{"text": "Published by Elsevier Inc.All rights reserved .Full - text \u00b7 Article \u00b7 Mar 2015 \u00b7 Journal of the American College of Cardiology .We present the first study to provide a 10-year clinical follow - up in an unselected patient population who underwent SES implantation .", "label": "", "metadata": {}, "score": "66.10134"}
{"text": "In contrast to balloon angioplasty , the phenomenon of \" in - stent \" restenosis is known to be caused by excessive neointimal proliferation at the site of the vessel injury , with little late vessel / stent recoil .", "label": "", "metadata": {}, "score": "66.217026"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : The first CE - approved bioresorbable vascular scaffold ( BVS ) is effective at treating simple lesions and stable coronary artery disease , but it has yet to be assessed versus the best - in - class drug - eluting stents ( DES ) .", "label": "", "metadata": {}, "score": "66.30578"}
{"text": "Three - year follow - up was available in 2,683 patients ( 99.1 % ) .At three - year follow - up , MACE as well as safety and efficacy measures including stent thrombosis were not statistically different between the biodegradable polymer - coated BES and the durable polymer - coated EES .", "label": "", "metadata": {}, "score": "66.61616"}
{"text": "Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus - eluting stents or bare metal stents .Pedro A Lemos Heart Institute InCor , University of Sao Paulo Medical School , Sao Paulo , Brazil Am J Cardiol 95:167 - 72 .", "label": "", "metadata": {}, "score": "66.621185"}
{"text": "Bill D Gogas Thoraxcenter , Erasmus University Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 5:656 - 65 .This study sought to investigate in vivo the vascular response at the proximal and distal edges of the second - generation ABSORB everolimus - eluting bioresorbable vascular scaffold ( BVS ) ... .", "label": "", "metadata": {}, "score": "66.68103"}
{"text": "Moreover , the safety and feasibility of OCT examination in a multicenter study has been demonstrated .Newer modalities of OCT image acquisition , as used in this study , have been reported to further simplify the technique and reduce procedural time .", "label": "", "metadata": {}, "score": "66.809265"}
{"text": "Department of Cardiology , University & Hospital .References .Dibra A , Kastrati A , Alfonso F , Seyfarth M , P\u00e9rez - Vizcayno MJ , Mehilli J , Sch\u00f6mig A : Effectiveness of drug - eluting stents in patients with bare - metal in - stent restenosis : meta - analysis of randomized trials .", "label": "", "metadata": {}, "score": "67.142265"}
{"text": "The impact of drug - eluting stent ( DES ) implantation on the incidence of major adverse cardiovascular events in patients undergoing percutaneous intervention for left main ( LM ) coronary disease is largely unknown ... .", "label": "", "metadata": {}, "score": "67.37585"}
{"text": "Results of the SIRIUS ( sirolimus - eluting stent in de - novo native coronary lesions ) trial , \" Journal of the American College of Cardiology , vol .", "label": "", "metadata": {}, "score": "67.4857"}
{"text": "CONCLUSIONS : BVS has fewer uncovered struts and presents with a thicker neointimal coverage compared with EES&BES .It is not known whether this improved capping correlates with superior vascular healing .", "label": "", "metadata": {}, "score": "67.58368"}
{"text": "In contrast , rates of CK - MB elevation were similar in those patients receiving an EES , and lower when compared to PES , regardless of the presence or absence of a jailed side branch .", "label": "", "metadata": {}, "score": "67.61787"}
{"text": "Finn and colleagues compared the CYPHER sirolimus - eluting stent to a BMS control and showed a higher grade of inflammation in CYPHER stents at 180 days , with evidence of granulomas in 60 % of arteries at 180 days [ 17 ] .", "label": "", "metadata": {}, "score": "67.707344"}
{"text": "Abstract .The complication of stent thrombosis ( ST ) emerged at a rate of 0.5 % annually for first - generation drug - eluting stents ( DES ) , often presenting as death or myocardial infarction .", "label": "", "metadata": {}, "score": "67.85344"}
{"text": "9644 , pp .1163 - 1173 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Wykrzykowska , P. Serruys , P. Buszman et al . , \" The three year follow - up of the randomised \" all - comers \" trial of a biodegradable polymer biolimus - eluting stent versus permanent polymer sirolimus - eluting stent ( LEADERS ) , \" EuroIntervention , vol .", "label": "", "metadata": {}, "score": "67.8826"}
{"text": "537 - 557 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . L. Bonello , U. S. Tantry , R. Marcucci et al . , \" Consensus and future directions on the definition of high on - treatment platelet reactivity to adenosine diphosphate , \" Journal of the American College of Cardiology , vol .", "label": "", "metadata": {}, "score": "67.8858"}
{"text": "25 , pp .3198 - 3206 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. W. Stone , S. G. Ellis , A. Colombo et al . , \" Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel - eluting and bare metal stent implantation , \" Circulation , vol .", "label": "", "metadata": {}, "score": "67.89041"}
{"text": "( Date:2/12/2016 ) ... , Feb. 12 , 2016 Sequent Medical , Inc. announced ... study to evaluate the safety and effectiveness of the ... of ruptured intracranial aneurysms .", "label": "", "metadata": {}, "score": "68.00292"}
{"text": "Nevertheless , late luminal loss was less than that observed with bare metal stents .To maintain the mechanical integrity of the device up to 6 months , the scaffold design and manufacturing process of its polymer were modified ... .", "label": "", "metadata": {}, "score": "68.13474"}
{"text": "48 , no . 1 , pp .193 - 202 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. V. Finn , G. Nakazawa , M. Joner et al . , \" Vascular responses to drug eluting stents : importance of delayed healing , \" Arteriosclerosis , Thrombosis , and Vascular Biology , vol .", "label": "", "metadata": {}, "score": "68.288574"}
{"text": "22 , pp .2842 - 2847 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Kotani , M. Awata , S. Nanto et al . , \" Incomplete neointimal coverage of sirolimus - eluting stents .", "label": "", "metadata": {}, "score": "68.29095"}
{"text": "46 - 56 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. Simon , J. C. Palmaz , and E. A. Sprague , \" Influence of topography on endothelialization of stents : clues for new designs , \" Journal of Long - Term Effects of Medical Implants , vol .", "label": "", "metadata": {}, "score": "68.35614"}
{"text": "1298 - 1309 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. W. Stone , D. R. Rutledge , K. Sudhir et al . , \" Stent thrombosis and dual antiplatelet interruption .", "label": "", "metadata": {}, "score": "68.37475"}
{"text": "Mean luminal diameter of the stent , peristent segments , and of a control vessel were determined at rest , during exercise , and after the administration of nitroglycerine .", "label": "", "metadata": {}, "score": "68.586716"}
{"text": "Chourmouzios A Arampatzis Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands Am J Cardiol 92:327 - 9 .The implantation of this stent was associated with abolition of post - discharge fatal events and percutaneous reintervention ... .", "label": "", "metadata": {}, "score": "68.916855"}
{"text": "We find that it is possible to ablate plaque just below the surface without causing surface damage , which motivates further investigation of ultrafast ablation for subsurface atherosclerotic plaque removal .", "label": "", "metadata": {}, "score": "68.9788"}
{"text": "5 , pp .333 - 342 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. V. Finn , M. Joner , G. Nakazawa et al . , \" Pathological correlates of late drug - eluting stent thrombosis : strut coverage as a marker of endothelialization , \" Circulation , vol .", "label": "", "metadata": {}, "score": "69.06202"}
{"text": "12 , pp .919 - 933 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. J. Price , P. B. Berger , P. S. Teirstein et al . , \" Standard- vs high - dose clopidogrel based on platelet function testing after percutaneous coronary intervention : the GRAVITAS randomized trial , \" Journal of the American Medical Association , vol .", "label": "", "metadata": {}, "score": "69.162544"}
{"text": "Inherent in the promise of this novel technology is the ultimate disappearance of the scaffold , which should in theory eliminate the long - term risk of device - related thrombosis .", "label": "", "metadata": {}, "score": "69.29805"}
{"text": "e21-e181 , 2009 .View at Google Scholar .G. I. Fishman , S. S. Chugh , J. P. Dimarco et al . , \" Sudden cardiac death prediction and prevention : report from a national heart , lung , and blood institute and heart rhythm society workshop , \" Circulation , vol .", "label": "", "metadata": {}, "score": "69.31035"}
{"text": "10.1016/S0140 - 6736(09)60325 - 1 View Article PubMed .Euro Intervention 2010 , 5 : 932 - 938 .PubMed .Rensing BJ , Vos J , Smits PC , Foley DP , van den Brand MJ , van der Giessen WJ , de Feijter PJ , Serruys PW : Coronary restenosis elimination with a sirolimus eluting stent ; First European human experience with 6-month angiographic and intravascular ultrasonic follow - up .", "label": "", "metadata": {}, "score": "69.352646"}
{"text": "Discussion .EVERBIO II is an independent , randomized study , aiming to compare the clinical efficacy , angiographic outcomes and safety of BVS , EES and BES in all comer patients .", "label": "", "metadata": {}, "score": "69.40085"}
{"text": "BACKGROUND The implantation of bare - metal stents ( BMS ) has significantly reduced clinical and angiographic restenosis compared to balloon angioplasty alone after PCI due to eliminating elastic recoil and reducing arterial remodeling .", "label": "", "metadata": {}, "score": "69.45112"}
{"text": "357 - 364 , 2012 .View at Google Scholar .S. Bangalore , S. Kumar , M. Fusaro et al . , \" Short- and long - term outcomes with drug - eluting and bare - metal coronary stents : a mixed - treatment comparison analysis of 117 762 patient - years of follow - up from randomized trials , \" Circulation , vol .", "label": "", "metadata": {}, "score": "69.45654"}
{"text": "Six - month and 2-year angiographic follow - up and clinical follow - up to 3 years were completed .At the 6-month and 2-year follow - ups , the calcified group ( compared with the noncalcified group ) had significantly higher rates of in - stent angiographic binary restenosis ( ABR ) and ischemia - driven ( ID ) TLR , resulting in numerically higher major cardiac adverse events ( MACE ) .", "label": "", "metadata": {}, "score": "69.475174"}
{"text": "No other extramural funding was used to support this work .Competing interests .SC has received educational grants from Abbott Vascular , Biosensors International and Boston Scientific .", "label": "", "metadata": {}, "score": "69.48826"}
{"text": "Imaging of atherosclerosis .Remodelling of coronary arteries .Gerard Pasterkamp Experimental Cardiology Laboratory , Heart Lung Institute , University Medical Center , ICIN , Utrecht J Cardiovasc Risk 9:229 - 35 .", "label": "", "metadata": {}, "score": "69.507416"}
{"text": "However , since the metallic thrombogenic stent surface could potentially remain uncovered by endothelium for prolonged periods of time , the additional complication of ST reemerged .", "label": "", "metadata": {}, "score": "69.57654"}
{"text": "1108 - 1113 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. Park , S. Park , K. Park et al . , \" Frequency of and risk factors for stent thrombosis after drug - eluting stent implantation during long - term follow - up , \" American Journal of Cardiology , vol .", "label": "", "metadata": {}, "score": "69.589226"}
{"text": "The first 115 lesions at selected study sites were predefined for inclusion in the optical coherence tomography ( OCT ) sub - study and 9-month follow - up ... .", "label": "", "metadata": {}, "score": "69.685715"}
{"text": "22 , pp .2335 - 2348 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. E. Cutlip , D. S. Baim , K. K. L. Ho et al . , \" Stent thrombosis in the modern Era : a pooled analysis of multicenter coronary stent clinical trials , \" Circulation , vol .", "label": "", "metadata": {}, "score": "69.85592"}
{"text": "To date , this mechanism has not been fully clarified .The aim of this study was to investigate the possibility of 64-slice multislice computed tomography ( MSCT ) to detect vulnerable plaque derived by optical coherence tomography .", "label": "", "metadata": {}, "score": "69.89603"}
{"text": "Safety and effectiveness of SES in acute myocardial infarction remain unknown ... . Short- and long - term clinical outcome after drug - eluting stent implantation for the percutaneous treatment of left main coronary artery disease : insights from the Rapamycin - Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries ( RES .", "label": "", "metadata": {}, "score": "70.01367"}
{"text": "This has resulted in the recommendation of a prolonged 12-month double antiplatelet therapy with aspirin and clopidogrel after drug - eluting stent implantation , however , how long double antiplatelet therapy is needed is unknown at present .", "label": "", "metadata": {}, "score": "70.07167"}
{"text": "Secondary endpoints included patient - oriented major acute coronary events ( MACE ) ( death , myocardial infarction [ MI ] , and any revascularization ) , device - oriented MACE ( cardiac death , MI , and target lesion revascularization ) , and stent thrombosis at the 9-month clinical follow - up .", "label": "", "metadata": {}, "score": "70.08225"}
{"text": "One propensity score matched registry ( LESSON-1 ) showed a trend towards a lower risk of death , myocardial infarction ( MI ) and target - vessel revascularization ( TVR ) as compared to SES over a 3-year follow - up [ 8 ] .", "label": "", "metadata": {}, "score": "70.09773"}
{"text": "We report on the procedural and six - month results of the first percutaneous and stand - alone study on myocardial repair with autologous skeletal myoblasts ... .", "label": "", "metadata": {}, "score": "70.172714"}
{"text": "9711 , pp .283 - 293 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .G. Montalescot , S. D. Wiviott , E. Braunwald et al . , \" Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST - elevation myocardial infarction ( TRITON - TIMI 38 ) : double - blind , randomised controlled trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "70.22504"}
{"text": "Patient has received any organ transplant or is on a waiting list for any organ transplant ; .Patient has a known hypersensitivity or contraindication to aspirin , heparin / bivalirudin , clopidogrel / ticlopidine , prasugrel , stainless steel alloy , sirolimus and/or contrast sensitivity that can not be adequately pre - medicated .", "label": "", "metadata": {}, "score": "70.290115"}
{"text": "17 , pp .1488 - 1497 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Wenaweser , J. Daemen , M. Zwahlen et al . , \" Incidence and correlates of drug - eluting stent thrombosis in routine clinical practice .", "label": "", "metadata": {}, "score": "70.38234"}
{"text": "18 , pp .2001 - 2009 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .O. C. Marroquin , F. Selzer , S. R. Mulukutla et al . , \" A comparison of bare - metal and drug - eluting stents for off - label indications , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "70.39576"}
{"text": "The primary endpoint will be percentage diameter stenosis at protocol - mandated 6 - 8 month angiographic follow - up .Sample size calculation is based on a non - inferiority assumption in relation to the BVS versus EES .", "label": "", "metadata": {}, "score": "70.480865"}
{"text": "EVERBIO II is an independent , randomized study , aiming to compare the clinical efficacy , angiographic outcomes and safety of BVS , EES and BES in all comer patients .", "label": "", "metadata": {}, "score": "70.50495"}
{"text": "Ostial target lesion(s ) .Totally occluded target vessel ( TIMI flow 0 ) .Calcified target lesion(s ) which can not be successfully predilated .", "label": "", "metadata": {}, "score": "70.5887"}
{"text": "9710 , pp .201 - 209 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .T. Palmerini , G. Biondi - Zoccai , D. D. Riva et al . , \" Stent thrombosis with drug - eluting and bare - metal stents : evidence from a comprehensive network meta - analysis , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "70.616135"}
{"text": "A total of 29 patients ( 92 coronary segments ) were imaged to evaluate the serial changes in necrotic core and dense calcium using Shin 's method .", "label": "", "metadata": {}, "score": "70.63287"}
{"text": "270 - 278 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Joner , G. Nakazawa , A. V. Finn et al . , \" Endothelial cell recovery between comparator polymer - based drug - eluting stents , \" Journal of the American College of Cardiology , vol .", "label": "", "metadata": {}, "score": "70.71839"}
{"text": "15 , pp .1851 - 1857 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . D. J. Kereiakes , J. K. Choo , J. J. Young , and T. M. Broderick , \" Thrombosis and drug - eluting stents : a critical appraisal , \" Reviews in Cardiovascular Medicine , vol .", "label": "", "metadata": {}, "score": "70.742584"}
{"text": "5 , pp .2026 - 2034 , 1994 .View at Google Scholar \u00b7 View at Scopus . A. Sch\u00f6mig , F. Neumann , A. Kastrati et al . , \" A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary - artery stents , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "70.810135"}
{"text": "Alexander N Kharlamov Thorax Center , Erasmus University Medical Center , Rotterdam , The Netherlands Int J Cardiol 165:217 - 21 .Potentially , more advanced imaging provides a chance to deliver infusate to the adventitial layer , which is a gate to the vessel wall for inflammation as well as a source of stem and progenitor cells , and myofibroblasts ... .", "label": "", "metadata": {}, "score": "70.81134"}
{"text": "Please refer to this study by its ClinicalTrials.gov identifier : NCT01080872 .Acute Coronary Syndrome Syndrome Angina Pectoris Cardiovascular Diseases Chest Pain Disease Heart Diseases Myocardial Ischemia Pain Pathologic Processes Signs and Symptoms Vascular Diseases .", "label": "", "metadata": {}, "score": "70.81328"}
{"text": "789 - 795 , 2011 .View at Google Scholar \u00b7 View at Scopus .B. Chevalier , S. Silber , S. Park et al . , \" Randomized comparison of the nobori biolimus A9- eluting coronary stent with the taxus libert\u00e9 paclitaxel - eluting coronary stent in patients with stenosis in native coronary arteries : The NOBORI 1 trial - phase 2 , \" Circulation , vol .", "label": "", "metadata": {}, "score": "71.085945"}
{"text": "The XIENCE V EES emerged in 2008 as a new option in DES .Following fav ...In the first study researchers from the Erasmus Medical Center in the ... .", "label": "", "metadata": {}, "score": "71.22061"}
{"text": "All patients will be monitored between 4 to 12 h in an intermediate care unit and will undergo baseline and 3 to 6 h cardiac biomarker measurements .", "label": "", "metadata": {}, "score": "71.30861"}
{"text": "DAPT interruption appears safe beyond 30 days in standard risk patients and beyond 6 months in an all - comers population that received the XIENCE V DES .", "label": "", "metadata": {}, "score": "71.44987"}
{"text": "18 , pp .2435 - 2441 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .P. Roy , D. H. Steinberg , S. J. Sushinsky et al . , \" The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug - eluting stents , \" European Heart Journal , vol .", "label": "", "metadata": {}, "score": "71.66196"}
{"text": "Findings from the SPIRIT III trial indicated that the newer generation of DES , the EES , was associated with fewer clinical events than the first generation PES .", "label": "", "metadata": {}, "score": "71.663284"}
{"text": "In Shin 's method contours are drawn around the IVUS catheter ( instead of delineating the lumen ) and the vessel .The mean necrotic core area decreased by 6.9 % from post - stenting to 6 months ( 1.71 \u00b1 1.03 mm2vs .", "label": "", "metadata": {}, "score": "71.92619"}
{"text": "The vessel diameter should be measured after pre - dilation procedure and after intra - coronary nitroglycerin if spasm is suspected 11 .Exclusion Criteria .", "label": "", "metadata": {}, "score": "71.940704"}
{"text": "104 - 111 , 1998 .View at Google Scholar \u00b7 View at Scopus . S. Hur , J. Ako , Y. Honda , K. Sudhir , and P. J. Fitzgerald , \" Late - acquired incomplete stent apposition : morphologic characterization , \" Cardiovascular Revascularization Medicine , vol .", "label": "", "metadata": {}, "score": "72.158264"}
{"text": "Late ST , more likely to occur with DES than with BMS , may result from the gradual release of the antiproliferative agent , effectively inhibiting endothelialization of the stent struts , allowing them to remain a nidus for platelet aggregation and thrombus formation .", "label": "", "metadata": {}, "score": "72.31094"}
{"text": "Our study showed high - clinical device success ( 98.7 % ) , excellent clinical procedural success ( 100 % ) , and the absence of MACE during the acute phase ( up to 30 days after stent implantation ) in the calcified group . \"", "label": "", "metadata": {}, "score": "72.39336"}
{"text": "The pre - specified endpoint at three years was major adverse cardiac events ( MACE ) , a composite of cardiac death , non - fatal myocardial infarction ( MI ) , or target vessel revascularisation ( TVR ) .", "label": "", "metadata": {}, "score": "72.40056"}
{"text": "One component of this deadly disease is the rupture or thin walled unstable plaques .Increased detection of rupture - prone vulnerable plaque could be promising for better risk stratification of patients .", "label": "", "metadata": {}, "score": "72.414505"}
{"text": "11 , pp .1097 - 1105 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. W. van Werkum , A. A. Heestermans , A. C. Zomer et al . , \" Predictors of coronary stent thrombosis : the Dutch Stent Thrombosis Registry , \" Journal of the American College of Cardiology , vol .", "label": "", "metadata": {}, "score": "72.42659"}
{"text": "Methods and results We enrolled 117 patients who underwent multislice computed tomography ( MSCT ) and OCT .EFV was quantified on MSCT .Patients were categorized according to ... .", "label": "", "metadata": {}, "score": "72.53596"}
{"text": "2873 - 2891 , 2012 .View at Google Scholar .S. Bangalore , S. Kumar , M. Fusaro et al . , \" Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus : mixed treatment comparison analysis of 22 , 844 patient years of follow - up from randomised trials , \" British Medical Journal , vol .", "label": "", "metadata": {}, "score": "72.789406"}
{"text": "1567 - 1572 , 2002 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . H. Sch\u00fchlen , A. Kastrati , J. Dirschinger et al . , \" Intracoronary stenting and risk for major adverse cardiac events during the first month , \" Circulation , vol .", "label": "", "metadata": {}, "score": "72.92903"}
{"text": "17 , pp .2126 - 2130 , 2005 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .S. Nakamura , A. Colombo , A. Gaglione et al . , \" Intracoronary ultrasound observations during stent implantation , \" Circulation , vol .", "label": "", "metadata": {}, "score": "72.970825"}
{"text": "It is generally recognized that elective dental , endoscopic and other procedures within the first year after DES implantation should be performed without discontinuation of either aspirin or clopidogrel , and elective surgery should be deferred if possible .", "label": "", "metadata": {}, "score": "73.00715"}
{"text": "84 ] .Current recommendations are for 12 months of dual antiplatelet therapy in most patients after PCI [ 85 ] .A considerably larger prospective , multicenter , randomized , double - blind trial is currently ongoing to assess the effectiveness and safety of 12 versus 30 months of DAPT in subjects undergoing PCI with DES and BMS [ 88 ] .", "label": "", "metadata": {}, "score": "73.04302"}
{"text": "Patient presents with cardiogenic shock .Patient has extensive peripheral vascular disease that precludes safe 6 French sheath insertion ; .Any significant medical condition which in the Investigator 's opinion may interfere with the patient 's optimal participation in the study .", "label": "", "metadata": {}, "score": "73.16609"}
{"text": "At a mean follow - up of 399 + /- 120 days , the survival - free of major adverse events was 95 % , with no patient requiring target lesion revascularization ... .", "label": "", "metadata": {}, "score": "73.46176"}
{"text": "CFR assessment will be performed at 6 - 8 months after stent implantation at the same time with OCT assessment .In - stent restenosis will be ruled out using OCT . .", "label": "", "metadata": {}, "score": "73.46658"}
{"text": "This kind of large - scale analysis could yield some onsets towards local practice optimisation based on anonymous dose indicator cross - comparison .Further effort should nevertheless be made in order to proceed towards an operator - based data analysis , thus allowing for an individual practice optimisation .", "label": "", "metadata": {}, "score": "73.91087"}
{"text": "If the patient is not accessible , data can be retrieved from the referring physician or the hospital electronic database .Statistical analyses .We plan to enroll 80 patients in each group .", "label": "", "metadata": {}, "score": "74.13498"}
{"text": "Current recommendations for dual antiplatelet therapy ( DAPT ) in PCI patients include aspirin and a thienopyridine , based on randomized trials showing reduced ST rates with aspirin plus clopidogrel or ticlopidine , compared to aspirin alone or aspirin plus warfarin [ 73 - 75 ] .", "label": "", "metadata": {}, "score": "74.33104"}
{"text": "Patient selection criteria .Patients must be apt and willing to provide written informed consent and participate in follow - up .Patients with a known or presumed hypersensitivity to heparin , antiplatelet drugs and hypersensitivity to contrast dye not controllable with standard premedication will be excluded .", "label": "", "metadata": {}, "score": "74.40665"}
{"text": "10.1161/CIRCULATIONAHA.110.971606 View Article PubMed .Gogas BD , Farooq V , Onuma Y , Serruys PW : The ABSORB bioresorbable vascular scaffold : an evolution or revolution in interventional cardiology ?", "label": "", "metadata": {}, "score": "74.51113"}
{"text": "Although human data are the best test of biocompatibility of DES , animal models can provide detailed systematic insights into tissue responses to DES under controlled conditions .", "label": "", "metadata": {}, "score": "74.5684"}
{"text": "The patient is enrolled to the BASE - ACS trial .Treated culprit lesion is in the proximal or middle LAD .Patient or the patient 's legal representative has been informed of the nature of the study and has provided written informed consent as approved by the Institutional Ethics Committee of the respective clinical site .", "label": "", "metadata": {}, "score": "74.650566"}
{"text": "There was also a noticeably lower presence of inflammation and foreign body reaction .Strut coverage , strut apposition and neointima can be quantified at a micron - scale level with a resolution 10 - 20 times higher than conventional intravascular ultrasound .", "label": "", "metadata": {}, "score": "74.74184"}
{"text": "3 I , pp .446 - 455 , 1999 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . E. Kedhi , G. W. Stone , D. J. Kereiakes et al . , \" Stent thrombosis : insights on outcomes , predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II , SPIRIT III , SPIRIT IV and COMPARE Trials , \" Eurointervention , vol . 8 , pp .", "label": "", "metadata": {}, "score": "74.80257"}
{"text": "Written informed consent will be obtained as required by the local institutional ethics committee in accordance with the Declaration of Helsinki .Treatment assignment .Patient randomization will be performed after lesion preparation .", "label": "", "metadata": {}, "score": "74.87781"}
{"text": "[ Time Frame : 60 days ] [ Designated as safety issue : No ] .Frequency of Abnormal Intrastent Tissue ( AIST ) .Secondary OCT Endpoints ( 10/12 )", "label": "", "metadata": {}, "score": "74.911804"}
{"text": "Sublingual nitroglycerin was associated with maximal vasodilatation of the peristent segments in both groups .Conclusion : Alike DES with durable polymer , stents with a biodegradable polymer are associated with exercise - induced paradoxical coronary vasoconstriction of the peristent segments .", "label": "", "metadata": {}, "score": "74.94154"}
{"text": "Chourmouzios A Arampatzis Department of Interventional Cardiology , Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands Catheter Cardiovasc Interv 63:57 - 60 .SES implantation for multivessel disease in a consecutive series of patients is associated with low incidence of adverse events .", "label": "", "metadata": {}, "score": "75.03441"}
{"text": "Francesco Saia Department of Interventional Cardiology , Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands Circulation 108:1927 - 9 . Short- and long - term clinical outcome after drug - eluting stent implantation for the percutaneous treatment of left main coronary artery disease : insights from the Rapamycin - Eluting and Taxus Stent Evaluated At Rotterdam Cardiology Hospital registries ( RES .", "label": "", "metadata": {}, "score": "75.40544"}
{"text": "Acknowledgment .This work was funded by Abbott Vascular .References . D. Lloyd - Jones , R. Adams , M. Carnethon , et al . , \" Heart disease and stroke statistics 2009 update : a report from the American Heart Association Statistics Committee and Stroke Statistics Committee , \" Circulation , vol .", "label": "", "metadata": {}, "score": "75.482056"}
{"text": "To gain insight into the mechanisms and time course of DES restenosis , we evaluated the characteristics of restenotic lesions of first generation DES using optical coherence tomography ( OCT ) .", "label": "", "metadata": {}, "score": "75.4908"}
{"text": "Drug - eluting stents ( DES ) have considerably reduced neointimal hyperplasia and significantly decreased the risk of restenosis compared to bare metal stents ( BMS ) [ 1 ] .", "label": "", "metadata": {}, "score": "75.548004"}
{"text": "This study sought to investigate quantitative and homogeneity differential echogenicity changes of the ABSORB scaffold ( 1.1 ) during the first year after implantation ... .", "label": "", "metadata": {}, "score": "75.593185"}
{"text": "Elvin Kedhi Department of Cardiology , Maasstad Ziekenhuis , Rotterdam , The Netherlands EuroIntervention 7:1376 - 85 .Stress and tissue Doppler echocardiographic evidence of effectiveness of myoblast transplantation in patients with ischaemic heart failure .", "label": "", "metadata": {}, "score": "75.63754"}
{"text": "- Give general information about radiation protection .DISCUSSION As radiation - induced erythema occur several days or weeks the X - ray exposure , it can be easily diagnosed as being caused by another factor , such as medication or allergy .", "label": "", "metadata": {}, "score": "75.894104"}
{"text": "Patrick W Serruys Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands EuroIntervention 9:1271 - 84 .Comparison of early outcome of percutaneous coronary intervention for unprotected left main coronary artery disease in the drug - eluting stent era with versus without intravascular ultrasonic guidance .", "label": "", "metadata": {}, "score": "75.90783"}
{"text": "Patrick W Serruys Thorax Center , Erasmus Medical Center , Gravendijkwal 230 , Rotterdam , The Netherlands J Am Coll Cardiol 58:1578 - 88 .The aim of this study was to demonstrate that the prevention of early scaffold area shrinkage of the ABSORB BVS ( Rev.1.1 , Abbott Vascular , Santa Clara , California ) was sustained and not simply delayed by a few months ... .", "label": "", "metadata": {}, "score": "76.19055"}
{"text": "Kengo Tanabe Division of Cardiology , Thoraxcenter , Erasmus MC , Rotterdam , The Netherlands Circulation 107:559 - 64 .We performed the TAXUS III trial to evaluate the feasibility and safety of paclitaxel - eluting stent for the treatment of in - stent restenosis ( ISR ) ... .", "label": "", "metadata": {}, "score": "76.232445"}
{"text": "Methods / Design .The EVERBIO II trial is a single - center , assessor - blinded , randomized trial .A total of 240 patients will be enrolled and randomly assigned into 3 groups of 80 with either BVS , EES or BES implantation .", "label": "", "metadata": {}, "score": "76.25093"}
{"text": "Multislice spiral computed tomography for the evaluation of stent patency after left main coronary artery stenting : a comparison with conventional coronary angiography and intravascular ultrasound .", "label": "", "metadata": {}, "score": "76.37104"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Background : Drug - eluting stents ( DES ) have been associated with local endothelial dysfunction in the segments proximal and distal to the stent ( peristent segments ) and increased thrombotic risk in long term follow - up .", "label": "", "metadata": {}, "score": "76.39504"}
{"text": "The rationale for the design of the \" combo - stent \" is therefore to combine a growth inhibiting substance with abluminal release with an endothelial progenitor cell attracting design to promote endothelial repair .", "label": "", "metadata": {}, "score": "76.395706"}
{"text": "Angiographic geometric changes of the lumen arterial wall after bioresorbable vascular scaffolds and metallic platform stents at 1-year follow - up .Josep Gomez - Lara Department of Interventional Cardiology , Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 4:789 - 99 .", "label": "", "metadata": {}, "score": "76.42973"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. A. Silva , S. R. Ramee , C. J. White et al . , \" Primary stenting in acute myocardial infarction : Influence of diabetes mellitus in angiographic results and clinical outcome , \" American Heart Journal , vol .", "label": "", "metadata": {}, "score": "76.500015"}
{"text": "Neointimal Hyperplasia ( NIH ) Volume .Original Secondary Outcome Measures ICMJE .Not Provided .Current Other Outcome Measures ICMJE .Not Provided .Original Other Outcome Measures ICMJE .", "label": "", "metadata": {}, "score": "76.546326"}
{"text": "Conclusions .ST represents a major complication of DES implants , usually leading to either cardiac death or MI .There is emerging evidence that second - generation stents , particularly XIENCE V , have significantly lower ST rates compared to first generation stents .", "label": "", "metadata": {}, "score": "76.6979"}
{"text": "Clinical follow - up for up to 5 years will be conducted by telephone .The primary endpoint is in - segment late lumen loss at 9 months measured by quantitative coronary angiography .", "label": "", "metadata": {}, "score": "76.745895"}
{"text": "Clinical follow - up for up to 5 years will be conducted by telephone .The primary endpoint is in - segment late lumen loss at 9 months measured by quantitative coronary angiography .", "label": "", "metadata": {}, "score": "76.745895"}
{"text": "Optical coherence tomography ( OCT ) is conducted in the first 30 patients of each group willing to undergo the aforementioned procedure .Percentage of malapposed struts , frequency of abnormal intrastent tissue , frequency of peristrut low intensity area and percent net volume obstruction will be assessed with the use of automated edge - detection system ( Illumien - optis ORW , St. Jude Medical , St. Paul , MN , USA ) .", "label": "", "metadata": {}, "score": "76.93713"}
{"text": "The primary endpoint was a composite of death , myocardial infarction ( MI ) and target vessel revascularisation ( TVR ) at two - year follow - up .", "label": "", "metadata": {}, "score": "77.13079"}
{"text": "Procedural Factors Predisposing to ST .Procedural factors such as stent underexpansion and malapposition are risk factors for ST [ 11 ] .A study using propensity - score matched analysis showed that patients undergoing IVUS - guided DES implantation had lower definite ST at 30 days and 12 months than those who had not received IVUS guidance [ 22 ] .", "label": "", "metadata": {}, "score": "77.14344"}
{"text": "TLR risk was maximal between 3 to 6 years .New lesion revascularization increased throughout the study period .Conclusion Incidence of TLR was maximal 3 to 6 years after SES implantation and decreased thereafter .", "label": "", "metadata": {}, "score": "77.21765"}
{"text": "Efficacy of percutaneous intramyocardial injections using a nonfluoroscopic 3-D mapping based catheter system .Pieter C Smits Department of Cardiology , Thoraxcentre , University Hospital Rotterdam , The Netherlands Cardiovasc Drugs Ther 16:527 - 33 .", "label": "", "metadata": {}, "score": "77.43565"}
{"text": "Methods / design : The EVERBIO II trial is a single - center , assessor - blinded , randomized trial .A total of 240 patients will be enrolled and randomly assigned into 3 groups of 80 with either BVS , EES or BES implantation .", "label": "", "metadata": {}, "score": "77.613266"}
{"text": "In an animal model , four different DES were examined to determine the extent of neointimal stent coverage [ 20 ] .Rabbits received CYPHER , TAXUS , the ENDEAVOR zotarolimus - eluting stent , or the XIENCE V everolimus - eluting stent .", "label": "", "metadata": {}, "score": "77.69063"}
{"text": "Of note , the benefits of DES in reducing restenosis and subsequent adverse events appear to offset a small excess risk of very late ST even with first - generation DES [ 42 ] .", "label": "", "metadata": {}, "score": "77.765366"}
{"text": "View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .J. Doostzadeh , L. N. Clark , S. Bezenek , W. Pierson , P. R. Sood , and K. Sudhir , \" Recent progress in percutaneous coronary intervention : evolution of the drug - eluting stents , focus on the XIENCE v drug - eluting stent , \" Coronary Artery Disease , vol .", "label": "", "metadata": {}, "score": "77.77373"}
{"text": "[89 ] was the first to suggest that DAPT interruption after 30 days does not increase the incidence of ST within the first postprocedure year when using the XIENCE V EES .", "label": "", "metadata": {}, "score": "78.1706"}
{"text": "We seek to compare the efficacy and safety profiles of these three different types and generations of DES .Study objectives and hypothesis .The null hypothesis to be rejected is that all three stents are of equal efficacy .", "label": "", "metadata": {}, "score": "78.221596"}
{"text": "b Secondary endpoints : patient oriented ( death , myocardial infarction , target vessel revascularization ) , device oriented ( cardiac death , myocardial infarction , target - lesion revascularization ) , stent thrombosis , binary restenosis at 9-month angiography study .", "label": "", "metadata": {}, "score": "78.287415"}
{"text": "Conclusions : This study suggests that PFO closure with APFO or CPFO is equally effective for the prevention of recurrent events .Residual shunt was more frequent at six months with CPFO , but was similar to APFO at later follow - up .", "label": "", "metadata": {}, "score": "78.4099"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Aims : To compare clinical outcome of Amplatzer PFO ( APFO ) to Cardia PFO ( CPFO ) occluder .", "label": "", "metadata": {}, "score": "78.73582"}
{"text": "Secondary endpoint : Coronary flow velocity at baseline and during adenosine - induced hyperemia 6 - 8 months after stent implantation .Association of CFR to unendotheliazed stent struts and stent malapposition .", "label": "", "metadata": {}, "score": "78.742096"}
{"text": "Conclusions : This first clinical study failed to demonstrate any significant difference regarding safety or efficacy between these two types and generations of drug - eluting stents ( DES ) .", "label": "", "metadata": {}, "score": "78.75925"}
{"text": "Radiation protection must thus become of prime importance and should be promoted by all possible means .EVALUATION We are developing a mobile application that will help the physician to evaluate his / her current state of practice regarding radiation protection .", "label": "", "metadata": {}, "score": "78.94344"}
{"text": "35 - 44 , 1992 .View at Google Scholar \u00b7 View at Scopus .S. Silber , S. Windecker , P. Vranckx , and P. W. Serruys , \" Unrestricted randomised use of two new generation drug - eluting coronary stents : 2-year patient - related versus stent - related outcomes from the RESOLUTE All Comers trial , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "79.10025"}
{"text": "Introduction .Cardiovascular disease accounts for roughly one - third of human mortality throughout the world [ 1 ] .Although the last five decades have seen impressive improvements in the diagnosis , evaluation , and therapeutic strategies in patients with symptomatic cardiovascular disease the majority of deaths still occur in patients with occult disease .", "label": "", "metadata": {}, "score": "79.43041"}
{"text": "4 , pp .342 - 352 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .R. J. Applegate , M. T. Sacrinty , M. A. Kutcher et al . , \" ' Off - label ' stent therapy .", "label": "", "metadata": {}, "score": "79.59572"}
{"text": "10.1016/S0140 - 6736(04)17275 - 9 View Article PubMed .Ong ATL , McFadden EP , Regar E , de Jaegere PPT , van Domburg RT , Serruys PW : Late angiographic stent thrombosis ( LAST ) events with drug - eluting stents .", "label": "", "metadata": {}, "score": "79.811554"}
{"text": "All patients will receive either a minimum 600 mg loading dose of clopidogrel , 180 mg of ticagrelor , or 60 mg prasugrel before or immediately after the procedure .", "label": "", "metadata": {}, "score": "79.922455"}
{"text": "Outcomes and follow - up were obtained in all 200 patients .The cumulative 10-year MACE rate was 47 % with all - cause death of 20 % , cardiac death of 9 % , myocardial infarction of 7 % , TLR and TVR of 8 % and 11 % respectively .", "label": "", "metadata": {}, "score": "80.06514"}
{"text": "BACKGROUND The number and complexity of interventional radiology and cardiology ( IR / IC ) procedures has been steadily increasing over the last twenty years .", "label": "", "metadata": {}, "score": "80.2494"}
{"text": "Methods and results : The primary endpoint was a composite of stroke , TIA , or peripheral embolism at follow - up .The secondary endpoint was residual shunt .", "label": "", "metadata": {}, "score": "80.32124"}
{"text": "Lesion and Patient - Related Factors .The type of lesion being treated and lesion morphology also influence healing after treatment with DES and can contribute to ST development .", "label": "", "metadata": {}, "score": "80.486404"}
{"text": "9562 , pp .667 - 678 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .M. Joner , A. V. Finn , A. Farb et al . , \" Pathology of drug - eluting stents in humans .", "label": "", "metadata": {}, "score": "80.593925"}
{"text": "In order to set up this optimisation process , the clinical practice for a given cardiology centre has to be analysed with relevant statistical power and compared with the data at local or national level .", "label": "", "metadata": {}, "score": "80.668205"}
{"text": "No preview \u00b7 Article \u00b7 Jul 2015 \u00b7 EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology .", "label": "", "metadata": {}, "score": "80.72238"}
{"text": "Aims Epicardial fat volume ( EFV ) has been implicated in coronary artery disease .Relationship between EFV and coronary plaque vulnerability has not been elucidated .", "label": "", "metadata": {}, "score": "80.78262"}
{"text": "Trial interruption .The trial will be halted should the incidence of clinical endpoints significantly differ between the different devices during the intermediate analysis .The trial will also be halted should the incidence of adverse clinical events exceed the expected values at any point .", "label": "", "metadata": {}, "score": "81.03776"}
{"text": "It uses a poly- l -lactide polymer that is absorbed after approximately 2 years via the Krebs cycle .A prospective , open - label , 2-stage study called ABSORB including 131 patients was conducted in Europe and New Zealand and led to its approval by the EU in January 2011 for the treatment of coronary artery lesions [ 14 ] .", "label": "", "metadata": {}, "score": "81.243546"}
{"text": "Secondary Clinical Endpoints : Stent thrombosis [ Time Frame : 30 , 60 , 180 , 360 , 540 days ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "81.352066"}
{"text": "Intervention ( PCI or bypass ) of another lesion in a non - target vessel performed within 30 days prior to the index .Planned intervention of another lesion ( target vessel or non - target vessel ) within 30 days .", "label": "", "metadata": {}, "score": "81.397736"}
{"text": "The Absorb \u2122 BVS is the first , fully bioresorbable coronary scaffold to have been launched for clinical use with CE approval .It uses a poly- l -lactide polymer that undergoes a four - stage bioresorption through hydration , depolymerization , polymer fragmentation and dissolution over 2 years via the Krebs cycle [ 26 ] .", "label": "", "metadata": {}, "score": "81.46982"}
{"text": "LLL is computed through quantitative coronary angiography with the use of automated edge - detection system ( CAAS II , Pie Medical Imaging , Maastricht , The Netherlands ) .", "label": "", "metadata": {}, "score": "81.93975"}
{"text": "624 - 629 , 2000 .View at Google Scholar \u00b7 View at Scopus .S. R. Mehta , S. Yusuf , R. J. G. Peters et al . , \" Effects of pretreatment with clopidogrel and aspirin followed by long - term therapy in patients undergoing percutaneous coronary intervention : the PCI - CURE study , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "81.96765"}
{"text": "Francesco Saia Erasmus MC , Thoraxcenter , Rotterdam , The Netherlands Catheter Cardiovasc Interv 61:455 - 60 . .13+ /- 0.34 and restenosis rate was 7.7 % .", "label": "", "metadata": {}, "score": "82.12103"}
{"text": "The AbsorbTM ( Abbott Vascular , Abbott Park , IL , USA ) is the first CE approved DES with a bioresorbable vascular scaffold ( BVS ) thought to reduce long - term complication rates .", "label": "", "metadata": {}, "score": "82.17461"}
{"text": "Participants were asked to record their HR with the Apple Watch Device during procedures , every - day life and control activities such as outpatient consultations , sport , marital conflicts and sexual intercourse .", "label": "", "metadata": {}, "score": "82.18944"}
{"text": "Two large clinical trials ( NOBORI and LEADERS ) proved its non - inferiority to PES and SES at 9 months and 4 years , respectively [ 9 , 10 ] .", "label": "", "metadata": {}, "score": "82.22246"}
{"text": "Recently , the randomized COMPARE II trial enrolling 2,707 patients , confirmed the BES safety but no differences were observed in clinical endpoints at 2-year follow - up when compared to EES [ 12 ] .", "label": "", "metadata": {}, "score": "82.81803"}
{"text": "10.1161/CIRCULATIONAHA.106.658237 View Article PubMed .Circulation 2009 , 120 : 391 - 399 .10.1161/CIRCULATIONAHA.109.854398 View Article PubMed .Onuma Y , Serruys PW : Bioresorbable scaffold : the advent of a new era in percutaneous coronary and peripheral revascularization ?", "label": "", "metadata": {}, "score": "82.81882"}
{"text": "Allocation concealment will be kept in sealed envelopes containing a non - transparent pleated color sheet in which the etiquette for intervention is embedded .The investigator is responsible for enrolment and a study nurse will assign participants to either stent implantation .", "label": "", "metadata": {}, "score": "82.92859"}
{"text": "Notably , endothelial repair can be substantially stimulated by CD34 + endothelial progenitor cells .The Combo stent is therefore covered with a CD34 + antibody to attract endothelial progenitor cells to promote endothelial and stent healing , and on the abluminal side releases sirolimus to prevent neointima formation and restenosis .", "label": "", "metadata": {}, "score": "83.05161"}
{"text": "ABSORB EXTEND 12-month outcomes in the first 450 patient enrolled .Abstract presented at the Rotterdam EuroPCR Focus on Bioresorbable Vascular Scaffolds , \" 2013 . A. Sch\u00f6mig , F. Neumann , A. Kastrati et al . , \" A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary artery stents , \" The New England Journal of Medicine , vol .", "label": "", "metadata": {}, "score": "83.20315"}
{"text": "Atherosclerotic plaque growth proceeds from the accumulation of fatty deposits , cholesterol , and cellular waste products in the inner layer of the coronary arteries .", "label": "", "metadata": {}, "score": "83.64745"}
{"text": "10.1016/j.jacc.2005.02.086 View Article PubMed .Circulation 2006 , 113 : 1108 - 1113 .10.1161/CIRCULATIONAHA.105.600155 View Article PubMed .Cook S , Wenaweser P , Togni M , Billinger M , Morger C , Seiler C , Vogel R , Hess O , Meier B , Windecker S : Incomplete stent apposition and very late stent thrombosis after drug - eluting stent implantation .", "label": "", "metadata": {}, "score": "83.66037"}
{"text": "10.1016/j.jacc.2006.10.049 View Article PubMed .Joner M , Finn AV , Farb A , Mont EK , Kolodgie FD , Ladich E , Kutys R , Skorija K , Gold HK , Virmani R : Pathology of drug - eluting stents in humans : delayed healing and late thrombotic risk .", "label": "", "metadata": {}, "score": "83.68931"}
{"text": "9281 , pp .527 - 533 , 2001 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .C. P. Cannon , R. A. Harrington , S. James et al . , \" Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes ( PLATO ) : a randomised double - blind study , \" The Lancet , vol .", "label": "", "metadata": {}, "score": "83.72273"}
{"text": "detected more luminal eosinophils but fewer para - strut giant cells with TAXUS stents at overlap compared to CYPHER stents at 1 and 3 months , with incomplete endothelialization [ 19 ] .", "label": "", "metadata": {}, "score": "84.11844"}
{"text": "Design : This is a single - centre observational study including a total of 6 male interventional cardiologists performing coronary interventions and pacemaker implantations .Participants were asked to record their heart rate ( HR ) via the Apple Watch Device during procedures , every - day life and control activities such as outpatient consultations , sport , marital conflicts and sexual intercourse .", "label": "", "metadata": {}, "score": "84.17636"}
{"text": "In the first study , researchers from the Erasmus Medical Center in the Netherlands identified 212 patients with 247 lesions , who were treated with EES alone .", "label": "", "metadata": {}, "score": "84.31369"}
{"text": "Collateral formation in patients after percutaneous myocardial revascularization : a mechanism for improvement ?Chi Hang Lee Department of Cardiology , Erasmus Medical Center Rotterdam , The Netherlands J Invasive Cardiol 15:488 - 90 .", "label": "", "metadata": {}, "score": "84.36495"}
{"text": "Secondary OCT Endpoints ( 8/12 )[ Time Frame : 60 days ] [ Designated as safety issue : No ] .Percentage of protruding struts per stent .", "label": "", "metadata": {}, "score": "84.444786"}
{"text": "Stent Volume .Secondary OCT Endpoints ( 11/12 )[ Time Frame : 60 days ] [ Designated as safety issue : No ] .Lumen Volume .", "label": "", "metadata": {}, "score": "84.615265"}
{"text": "Complex cardiac procedures were associated with higher heart rates up to 122 bpm .Peak heart rates were higher during physical exertion .Some subjects complained of hypersexuality and mania after night shifts .", "label": "", "metadata": {}, "score": "84.840836"}
{"text": "Index percutaneous coronary intervention .Procedures will be performed via the femoral or radial artery with a 5 - 6 French ( F ) guiding catheter .", "label": "", "metadata": {}, "score": "85.041016"}
{"text": "242 - 248 , 1975 .View at Google Scholar \u00b7 View at Scopus . D. Kiaei , A. S. Hoffman , and T. A. Horbett , \" Tight binding of albumin to glow discharge treated polymers , \" Journal of Biomaterials Science , vol .", "label": "", "metadata": {}, "score": "85.06569"}
{"text": "As for the staff , it will help them with their daily practice by giving them useful tips aiming to reduce the dose delivered to the patient and , as a consequence , their own personal dose .", "label": "", "metadata": {}, "score": "85.19577"}
{"text": "The collected dose indicators were , when available , cumulated air kerma , cumulated dose - area product , fluoroscopy time and the number of images per procedure .", "label": "", "metadata": {}, "score": "85.353546"}
{"text": "Pedro A Lemos Department of Cardiology , Thoraxcenter , Erasmus Medical Center Rotterdam , Rotterdam , The Netherlands Am J Cardiol 93:633 - 6 .The 12-month target lesion revascularization rate was 5.5 % .", "label": "", "metadata": {}, "score": "85.4473"}
{"text": "International Journal of Cardiovascular Imaging , 1 - 7 .doi:10.1007/s10554 - 010 - 9739 - 4", "label": "", "metadata": {}, "score": "85.89335"}
{"text": "Subsequent clinical follow - up will be undertaken out to 5 years .Choosing to participate in a study is an important personal decision .Talk with your doctor and family members or friends about deciding to join a study .", "label": "", "metadata": {}, "score": "85.99788"}
{"text": "For general information , see Learn About Clinical Studies .Please refer to this study by its ClinicalTrials.gov identifier : NCT01942070 .Myocardial Infarction Cardiovascular Diseases Infarction Heart Diseases Ischemia Myocardial Ischemia Necrosis Pathologic Processes Vascular Diseases Everolimus Sirolimus .", "label": "", "metadata": {}, "score": "86.04552"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : CONCLUSION The promotion of radiation protection must be done using all available means .The tremendous growth of mobile devices in the recent years called for a gap to be filled .", "label": "", "metadata": {}, "score": "86.14866"}
{"text": "356 , no .10 , pp .1020 - 1029 , 2007 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus . A. J. Kirtane , A. Gupta , S. Iyengar et al . , \" Safety and efficacy of drug - eluting and bare metal stents : comprehensive meta - analysis of randomized trials and observational studies , \" Circulation , vol .", "label": "", "metadata": {}, "score": "86.273705"}
{"text": "- Estimate the risk and severity of potential radiation - induced skin burns and the necessity of patient follow - up .- Estimate one 's average personal dose .", "label": "", "metadata": {}, "score": "86.34619"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Background : It is inferred that interventional cardiologists may be immune to stress allowing them to perform complex percutaneous interventions under pressure .", "label": "", "metadata": {}, "score": "86.426636"}
{"text": "Target lesion ( maximum length is 20 mm by visual estimate ) to be covered by a single stent of max 23 mm ( stent coverage incl at least 3 mm of healthy vessel is recommended ) .", "label": "", "metadata": {}, "score": "86.601814"}
{"text": "286 - 294 , 2006 .View at Google Scholar .R. J. Petersen and L. T. Rozelle , \" Ethylcellulose perfluorobutyrate : a highly non - thrombogenic fluoropolymer for gas exchange membranes , \" Transactionsof the American Society for Artificial Internal Organs , vol .", "label": "", "metadata": {}, "score": "86.63726"}
{"text": "Secondary OCT Endpoints ( 1/12 )[ Time Frame : 60 days ] [ Designated as safety issue : No ] .Percentage of stent strut malapposition .", "label": "", "metadata": {}, "score": "86.74666"}
{"text": "A recent pooled analysis showed that the risk of ST was inversely related to age , with younger patients showing a higher incidence [ 35 ] , a noteworthy finding given that older patients are known to have a higher incidence of bleeding after PCI [ 36 ] .", "label": "", "metadata": {}, "score": "86.96655"}
{"text": "10.1016/j.jacc.2011.01.023 View Article PubMed .Circ Cardiovasc Interv 2009 , 2 : 188 - 195 .10.1161/CIRCINTERVENTIONS.108.823443 View Article PubMed .Lancet 2011 , 378 : 1940 - 1948 .", "label": "", "metadata": {}, "score": "86.99417"}
{"text": "Clinical follow - up is scheduled at 30 , 60 , 180 , 360 and 540 days .Furthermore , QCA and OCT will also be performed at baseline in all participants of the study .", "label": "", "metadata": {}, "score": "87.06761"}
{"text": "Diffuse distal disease to target lesion with impaired runoff .Pre - treatment with devices other than balloon angioplasty .Prior stent within 10 mm of target lesion .", "label": "", "metadata": {}, "score": "87.330185"}
{"text": "BES is a metallic stent that uses an abluminal bioresorbable polymer coating .This polymer is completely converted to lactic acid by 6 months and , via the Krebs cycle , to carbon dioxide and water by 6 to 9 months .", "label": "", "metadata": {}, "score": "87.7019"}
{"text": "Methods / Design .Study design and overview .This is a single center , assessor - blinded , randomized study comparing three different stents in de novo coronary lesions : the Absorb \u2122 , the Promus Element \u2122 and the Biomatrix Flex \u2122 .", "label": "", "metadata": {}, "score": "87.870926"}
{"text": "Complex cardiac procedures were associated with higher HR up to 122 bpm .Peak HR were higher during physical exertion .Of note , participants complained of hypersexuality and mania after night shifts .", "label": "", "metadata": {}, "score": "87.97031"}
{"text": "Patient willing to comply with specified follow - up .Patient or legally authorized representative has been informed of the nature of the study , agrees to its provisions and has been provided written informed consent .", "label": "", "metadata": {}, "score": "88.16484"}
{"text": "Caroline E Veltman Department of Cardiology , Erasmus University Medical Centre , Thoraxcentre , Room Ba 587 , Erasmus MC , Gravendijkwal 230 , PO Box 2040 , 3015 CE Rotterdam , The Netherlands Eur Heart J 29:1386 - 96 .", "label": "", "metadata": {}, "score": "88.216354"}
{"text": "The Absorb \u2122 ( Abbott Vascular , Abbott Park , IL , USA ) is the first CE approved DES with a bioresorbable vascular scaffold ( BVS ) thought to reduce long - term complication rates .", "label": "", "metadata": {}, "score": "88.418564"}
{"text": "Authors ' contributions .DA drafted this manuscript .SP performed the statistical planning .SJ , HV , EB and NC participated in data acquisition .", "label": "", "metadata": {}, "score": "88.514694"}
{"text": "Objectives : To assess heart rate ( HR ) variations as a surrogate marker of stress of interventional cardiologists during percutaneous cardiac procedures and in every - day life .", "label": "", "metadata": {}, "score": "88.9612"}
{"text": "Cihan Simsek Department of Cardiology , Thoraxcenter , Erasmus Medical Center Rotterdam , Dr Molewaterplein 40 , Rotterdam , The Netherlands Catheter Cardiovasc Interv 76:41 - 9 .", "label": "", "metadata": {}, "score": "88.98303"}
{"text": "The principal investigator is continuously informed by the DSMB and CAEC and is , by not being blinded , solely responsible for trial halting .Discussion .", "label": "", "metadata": {}, "score": "89.169556"}
{"text": "Female patients of childbearing potential must have a negative pregnancy test done within 7 days prior to the index procedure per site standard test .Impaired renal function or on dialysis .", "label": "", "metadata": {}, "score": "89.42346"}
{"text": "Left ventricular apical ballooning .Reza Alizadeh Dehnavi Vascular Medicine , Department of General Internal Medicine and Endocrinology , Leiden University Medical Centre , Leiden , The Netherlands Int J Cardiovasc Imaging 22:327 - 31 .", "label": "", "metadata": {}, "score": "89.64766"}
{"text": "Polymorphisms in the gene encoding the CYP2C19 allele , as well as heightened onclopidogrel platelet reactivity , have been associated with adverse clinical events in patients undergoing PCI [ 78 , 79 ] .", "label": "", "metadata": {}, "score": "89.715546"}
{"text": "( PRWEB ) , ... February 12 , 2016 , ... ...Lean Leadership Series at Zuckerberg San Francisco General Hospital on April 5 - 7 .", "label": "", "metadata": {}, "score": "90.90342"}
{"text": "Full - text \u00b7 Article \u00b7 Jan 2016 \u00b7 Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases , the Swiss Society of Internal Medicine , the Swiss Society of Pneumology .", "label": "", "metadata": {}, "score": "90.99606"}
{"text": "Pedro A Lemos Department of Cardiology , Thoraxcenter , Erasmus Medical Center , Dr Molewaterplein 40 , NL 3015 GD Rotterdam , The Netherlands J Am Coll Cardiol 41:2093 - 9 .", "label": "", "metadata": {}, "score": "91.06496"}
{"text": "Josep Gomez - Lara Department of Interventional Cardiology , Thoraxcenter , Erasmus Medical Center , Rotterdam , The Netherlands JACC Cardiovasc Interv 4:1271 - 80 .", "label": "", "metadata": {}, "score": "92.83823"}
{"text": "The recruitment phase is complete as of November 2013 .Declarations .Acknowledgements .This study was funded by the Fonds Scientifique Cardiovasculaire , Fribourg , Switzerland .", "label": "", "metadata": {}, "score": "93.16632"}
{"text": "Each year , the American Physical Therapy Association ( APTA ) offers a Combined Sections Meeting . ...Almost 10,000 physical therapists across the country are expected to attend this annual convention ... field and network with their colleagues .", "label": "", "metadata": {}, "score": "93.680534"}
{"text": "[ Time Frame : 60 days ] [ Designated as safety issue : No ] .Total malapposition volume .Secondary OCT Endpoints ( 6/12 )", "label": "", "metadata": {}, "score": "94.27321"}
{"text": "The ideal duration of antiplatelet therapy is unclear .For BMS - treated patients , while a minimum of 2 - 4 weeks of dual - antiplatelet therapy is recommended , 12 months may be optimal , especially in patients with acute coronary syndromes .", "label": "", "metadata": {}, "score": "94.434494"}
{"text": "PubMed .Lancet 2013 , 381 : 651 - 660 .10.1016/S0140 - 6736(12)61852 - 2 View Article PubMed .Jukema JW , Ahmed TA , Verschuren JJ , Quax PH : Restenosis after PCI .", "label": "", "metadata": {}, "score": "94.46689"}
{"text": "Interventional .Study Phase .Phase 2 .Study Design ICMJE .Allocation : Randomized Endpoint Classification : Safety / Efficacy Study Intervention Model : Parallel Assignment Masking : Single Blind ( Subject ) Primary Purpose : Treatment .", "label": "", "metadata": {}, "score": "94.58308"}
{"text": "There are limited data regarding the frequency and distribution of TCFA in diseased coronary arteries .Methods : Coronary artery OCT ... . ... ; Mitsuyasu Terashima ; Tsuyoshi Ito ; Nobuyoshi Tanaka ; Kenya Nasu ; Tatsuya Ito ; Masashi Kimura ; Mariko Ehara ; Yoshihisa Kinoshita ; Etsuo Tsuchikane ; Yasushi Asakura ; Osamu Katoh ; Takahiko Suzuki Toyohashi Heart Cntr , Toy ... . ... toshi Matsuo ; Mariko Ehara ; Toshikazu Matsushita ; Kenya Nasu ; Masashi Kimura ; Nobuyoshi Tanaka ; Maoto Habara ; Yoshihisa Kinoshita ; Yasushi Asakura ; Etsuo Tsuchikane ; Osamu Kato ; Takahiko Suzuki Toyohashi Heart Cntr , Toyo ... .", "label": "", "metadata": {}, "score": "95.062454"}
{"text": "Disclosures .James B. Hermiller is research consultant for Abbott Vascular , consultant for St. Jude Medical and Boston Scientific , and speaker bureau for Eli Lilly and Company .", "label": "", "metadata": {}, "score": "95.46741"}
{"text": "Patients will be followed clinically by clinic visits or by telephone interview at 3 , 6 , 9 and 12 months , and 2 and 5 years .", "label": "", "metadata": {}, "score": "95.70358"}
{"text": "The primary outcome is analyzed using a parametric or nonparametric test according to distribution and by the computation of a multivariate linear analysis by taking into account significant risk factors that potentially influence outcome thus adjusting for them .", "label": "", "metadata": {}, "score": "95.78847"}
{"text": "SC conceived and designed the research , made critical revision of the manuscript for important intellectual content and handled funding and supervision .The authors read and approved the final manuscript .", "label": "", "metadata": {}, "score": "95.89279"}
{"text": "Maximal malapposition volume .Secondary OCT Endpoints ( 7/12 ) [ Time Frame : 60 days ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "96.36102"}
{"text": "Clinical site : Satakunta Central Hospital , Finland Turku University Hospital , Finland .Patients with acute coronary syndrome who were treated with BAS or EES during index PCI .", "label": "", "metadata": {}, "score": "96.9704"}
{"text": "10.1016/S0140 - 6736(09)62127 - 9 View Article PubMed .J Am Coll Cardiol 2011 , 58 : 1844 - 1854 .10.1016/j.jacc.2011.07.031 View Article PubMed .", "label": "", "metadata": {}, "score": "97.535866"}
{"text": "All members of the CEAC are blinded to the primary results of the trial .The study complies with the Declaration of Helsinki and was approved by the local ethics committee of Fribourg University and Hospital ( Switzerland , 043/12-CER - FR ) .", "label": "", "metadata": {}, "score": "97.733505"}
{"text": "[ Show abstract ] [ Hide abstract ] ABSTRACT : Coronary heart disease affects 2 - 6 % of the general population ; in the USA , it is responsible for more than 400,000 deaths each year .", "label": "", "metadata": {}, "score": "97.83768"}
{"text": "View at Publisher \u00b7 View at Google Scholar . K. Sudhir , J. B. Hermiller , S. S. Naidu et al . , \" on behalf of the XIENCE V USA Investigators .", "label": "", "metadata": {}, "score": "97.87366"}
{"text": "MI ( Q wave or non - Q wave ) .Secondary Clinical Endpoints : components of MACE : CABG or re - PTCA of target lesion [ Time Frame : 30 , 60 , 180 , 360 , 540 days ] [ Designated as safety issue : Yes ] .", "label": "", "metadata": {}, "score": "98.215775"}
{"text": "Nat Rev Cardiol 2012 , 9 : 79 - 90 .View Article .Lancet 2008 , 371 : 899 - 907 .10.1016/S0140 - 6736(08)60415 - 8 View Article PubMed .", "label": "", "metadata": {}, "score": "98.45898"}
{"text": "10.1053/euhj.2001.2892 View Article PubMed .N Engl J Med 2002 , 346 : 1773 - 1780 .10.1056/NEJMoa012843 View Article PubMed .", "label": "", "metadata": {}, "score": "98.578415"}
{"text": "Insight from the ABSORB cohort B trial , \" Heart , vol .99 , pp .98 - 105 , 2013 .View at Google Scholar .", "label": "", "metadata": {}, "score": "99.94777"}
{"text": "10.1056/NEJMoa0910496 View Article PubMed .J Am Coll Cardiol 2011 , 58 : 1325 - 1331 .10.1016/j.jacc.2011.06.027 View Article PubMed .", "label": "", "metadata": {}, "score": "100.01996"}
{"text": "Both .Ages .18 Years to 80 Years .Accepts Healthy Volunteers .No .Contacts ICMJE .Contact information is only displayed when the study is recruiting subjects Abstract .", "label": "", "metadata": {}, "score": "100.829475"}
{"text": "Secondary OCT Endpoints ( 4/12 ) [ Time Frame : 60 days ] [ Designated as safety issue : No ] .Maximum malapposition distance ( mm ) .", "label": "", "metadata": {}, "score": "101.426285"}
{"text": "c Usual laboratory survey include , complete blood count , electrolytes , fasting glucose level , INR , prothrombin time , partial thromboplastin time , creatinine , blood urea nitrogen , pregnancy test if applicable .", "label": "", "metadata": {}, "score": "101.77634"}
{"text": "Maximum length of segments ( mm ) with uncovered struts .Secondary OCT Endpoints ( 3/12 )[ Time Frame : 60 days ] [ Designated as safety issue : No ] .", "label": "", "metadata": {}, "score": "101.86478"}
{"text": "The organization and scientific conduct is supervised by a Steering Committee .A Data and Safety Monitoring Board is responsible for safety and ethical aspects .", "label": "", "metadata": {}, "score": "102.98886"}
{"text": "CK creatine kinase , ECG electrocardiogram .Study endpoints .The primary endpoint is LLL at 9 months as assessed by quantitative coronary angiography .The secondary endpoints are divided in angiographic and clinical findings .", "label": "", "metadata": {}, "score": "103.41927"}
{"text": "Parastrut fibrin was more frequent in TAXUS than in CYPHER , and fibrin scores were greater in overlapped sections of both DES ; fibrin was associated with stent malapposition [ 18 ] .", "label": "", "metadata": {}, "score": "104.85556"}
{"text": "Chi Hang Lee Cardiac Department , National University Hospital , Level 3 , Main Building 5 , Lower Kent Ridge Road , Singapore , 119074 J Invasive Cardiol 16:627 - 31 .", "label": "", "metadata": {}, "score": "105.22829"}
{"text": "Shin 's method may be offer a more suitable technique for this analysis because it includes all the contents of both the lumen and vessel wall .", "label": "", "metadata": {}, "score": "105.74812"}
{"text": "Primary Completion Date .August 2012 ( final data collection date for primary outcome measure ) .Eligibility Criteria ICMJE .Inclusion Criteria .ST or Non - ST - segment elevation MI ( assumed to be a type 1 ) .", "label": "", "metadata": {}, "score": "107.140274"}
{"text": "Paul Steendijk Department of Cardiology , Leiden University Medical Center , Leiden , The Netherlands Nat Clin Pract Cardiovasc Med 3:S94 - 100 .", "label": "", "metadata": {}, "score": "107.7154"}
{"text": "[ Time Frame : 30 , 60 , 180 , 360 , 540 days ] [ Designated as safety issue : Yes ] .Secondary Clinical Endpoint : components of MACE : cardiac death [ Time Frame : 30 , 60 , 180 , 360 , 540 days ] [ Designated as safety issue : Yes ] . cardiac death .", "label": "", "metadata": {}, "score": "108.06154"}
{"text": "Binary logistic regression is equally performed in the search of independent predictors for the secondary endpoints .All analyses are performed according to the intention - to - treat principle .", "label": "", "metadata": {}, "score": "108.159645"}
{"text": "10.1056/NEJMoa035071 View Article PubMed .N Engl J Med 2004 , 350 : 221 - 231 .10.1056/NEJMoa032441 View Article PubMed .", "label": "", "metadata": {}, "score": "109.80655"}
{"text": "( Date:2/12/2016 ) ... ...2016 , ... Coco Libre , the maker of coconut water beverages with a ...Lounge Event .Coco Libre will offer musicians and celebrities the company 's signature Organic Coconut ... invitation - only gifting suite , held this year at the W Hollywood Hotel , has become a ... .", "label": "", "metadata": {}, "score": "109.95017"}
{"text": "Labome .Org \u00a9 2015 All Rights Researved Princeton , New Jersey 08540 , USA Current Secondary Outcome Measures ICMJE ( submitted : August 31 , 2011 ) .", "label": "", "metadata": {}, "score": "110.63185"}
{"text": "Talk with your doctor and family members or friends about deciding to join a study .To learn more about this study , you or your doctor may contact the study research staff using the Contacts provided below .", "label": "", "metadata": {}, "score": "111.7529"}
{"text": "9665 , pp .723 - 731 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .122 , no .", "label": "", "metadata": {}, "score": "112.298386"}
{"text": "Continuous variables are presented as mean \u00b1 standard deviation or median ( 25 % to 75 % ) interquartile range according to their distribution .Categorical variables are presented as counts and percentages .", "label": "", "metadata": {}, "score": "112.94452"}
{"text": "16 , pp .1399 - 1409 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .4 , no .", "label": "", "metadata": {}, "score": "114.56757"}
{"text": "17 , pp .1084 - 1089 , 1996 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .102 , no .", "label": "", "metadata": {}, "score": "115.96718"}
{"text": "PubMed .Copyright .\u00a9 Arroyo et al . ; licensee BioMed Central Ltd. 2014 .This article is published under license to BioMed Central Ltd.", "label": "", "metadata": {}, "score": "116.20325"}
{"text": "Tsuyoshi Ito , MD , 4 .Tairo Kurita , MD , 5 .Nobuyoshi Tanaka , MD , 6 .Masashi Kimura , MD , 7 .", "label": "", "metadata": {}, "score": "116.914246"}
{"text": "Yoshihisa Kinoshita , MD , 9 .Etsuo Tsuchikane , MD , 10 .Keiko Asakura , MD , 11 .Yasushi Asakura , MD , 12 .... .", "label": "", "metadata": {}, "score": "117.267715"}
{"text": "11 - 18 , 2011 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .4 , no .10 , pp .", "label": "", "metadata": {}, "score": "118.14999"}
{"text": "47 , no .10 , pp .2108 - 2111 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "118.60447"}
{"text": "120 , no .22 , pp .2271 - 2306 , 2009 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "119.59787"}
{"text": "52 , no .14 , pp .1134 - 1140 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "120.23065"}
{"text": "The workshops cover a broad range of ... .( Date:2/12/2016 ) ...PITTSBURGH , Pa. ( PRWEB ) , ... February 12 , 2016 , ... ... space heaters .", "label": "", "metadata": {}, "score": "121.78282"}
{"text": "6 , pp .1035 - 1041 , 2010 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .5 , pp .", "label": "", "metadata": {}, "score": "123.61311"}
{"text": "51 , no .6 , pp .607 - 614 , 2008 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "123.66717"}
{"text": "125 , no .16 , pp .2015 - 2026 , 2012 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .", "label": "", "metadata": {}, "score": "126.51227"}
{"text": "352 - 356 , 2006 .View at Publisher \u00b7 View at Google Scholar \u00b7 View at Scopus .29 , no . 1 , pp .", "label": "", "metadata": {}, "score": "126.74492"}
{"text": "Received 20 May 2013 ; Accepted 6 June 2013 .Academic Editors : A. Becker and F. Cademartiri .Copyright \u00a9 2013 Krishnankutty Sudhir et al .", "label": "", "metadata": {}, "score": "127.67087"}
